Citations
Product Citations List
The QuidelOrtho Specialty Products Group (SPG) has a broad portfolio for Bone/Renal health and Autoimmune/Complement System products. Our selection of ELISA kits, antibodies, proteins, sera, and reagents have been featured in thousands of peer reviewed articles. Use the drop-down menus below to target a protein or product of interest to see how it has been successfully used by the scientific community.
| Area | Protein | Product Type | Sample Species | Catalog# | Product Title | Year | Citation Link | Applications | Sample Type | Sample Details |
|---|---|---|---|---|---|---|---|---|---|---|
| Complement System | C3 | EIA Kit | Porcine | 20261 | Pan-Specific C3 Reagent Kit | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28803115 | ELISA | Serum | |
| Bone/Renal | PTH | Antibody | Mouse | 21-2310 | Mouse PTH Antibody (53-84) | 2018 | https://pubmed.ncbi.nlm.nih.gov/29381784/ | IP, WB | Liver Tissue | |
| Bone/Renal | PTH | Antibody | Mouse | 21-2310 | Mouse PTH Antibody (53-84) | 2018 | https://pubmed.ncbi.nlm.nih.gov/29381784/ | IP, WB | Parathyroid Tissue | |
| Bone/Renal | PTH | Antibody | Mouse | 21-2310 | Mouse PTH Antibody (53-84) | 2018 | https://pubmed.ncbi.nlm.nih.gov/29381784/ | IP, WB | Thymus Tissue | |
| Bone/Renal | PTH | Antibody | Mouse | 21-2320 | Mouse PTH Antibody (1-12) | 2018 | https://pubmed.ncbi.nlm.nih.gov/29381784/ | IHC, IP, WB | Liver Tissue | |
| Bone/Renal | PTH | Antibody | Mouse | 21-2320 | Mouse PTH Antibody (1-12) | 2018 | https://pubmed.ncbi.nlm.nih.gov/29381784/ | IHC, IP, WB | Parathyroid Tissue | |
| Bone/Renal | PTH | Antibody | Mouse | 21-2320 | Mouse PTH Antibody (1-12) | 2018 | https://pubmed.ncbi.nlm.nih.gov/29381784/ | IHC, IP, WB | Thymus Tissue | |
| Bone/Renal | FGF-23 | Antibody | Human | 21-6110 | FGF-23 Ab (C-term 186-206) | 2012 | https://pubmed.ncbi.nlm.nih.gov/22689697/ | IP, WB | Plasma | |
| Bone/Renal | FGF-23 | Antibody | Human | 21-6120 | FGF-23 Ab (C-term 225-244) | 2019 | https://pubmed.ncbi.nlm.nih.gov/31476437/ | IHC | Neurofibromas | |
| Bone/Renal | FGF-23 | Antibody | Human | 21-6120 | FGF-23 Ab (C-term 225-244) | 2019 | https://pubmed.ncbi.nlm.nih.gov/31476437/ | IHC | Skin Tissue | |
| Bone/Renal | FGF-23 | Antibody | Human | 21-6120 | FGF-23 Ab (C-term 225-244) | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/24459137 | IHC | Artery Tissue | |
| Bone/Renal | FGF-23 | Antibody | Human | 21-6120 | FGF-23 Ab (C-term 225-244) | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25774916 | IHC, WB | Bone Tissue | |
| Bone/Renal | FGF-23 | Antibody | Human | 21-6120 | FGF-23 Ab (C-term 225-244) | 2012 | https://pubmed.ncbi.nlm.nih.gov/22689697/ | IP, WB | Plasma | |
| Bone/Renal | FGF-23 | Antibody | Human | 21-6120 | FGF-23 Ab (C-term 225-244) | 2010 | https://www.ncbi.nlm.nih.gov/pubmed/19965919 | WB | Plasma | |
| Bone/Renal | FGF-23 | Antibody | Human | 21-6120 | FGF-23 Ab (C-term 225-244) | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22689697 | WB | Plasma | |
| Bone/Renal | FGF-23 | Antibody | Mouse | 21-6310 | Mouse FGF-23 Ab (186-206) | 2019 | https://pubmed.ncbi.nlm.nih.gov/31237611/ | IP, WB | Bone Tissue | |
| Bone/Renal | FGF-23 | Antibody | Mouse | 21-6320 | Mouse FGF-23 Ab (225-244) | 2019 | https://pubmed.ncbi.nlm.nih.gov/31237611/ | IP, WB | Bone Tissue | |
| Bone/Renal | Osteocalcin | EIA Kit | Mouse | 60-1305 | Mouse Osteocalcin ELISA | 2014 | https://pubmed.ncbi.nlm.nih.gov/24652796/ | ELISA | Plasma | |
| Bone/Renal | Osteocalcin | EIA Kit | Mouse | 60-1305 | Mouse Osteocalcin ELISA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25872143 | ELISA | Serum | |
| Bone/Renal | Osteocalcin | EIA Kit | Mouse | 60-1305 | Mouse Osteocalcin ELISA | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28057769 | ELISA | Serum | |
| Bone/Renal | Osteocalcin | EIA Kit | Rat | 60-1505 | Rat Osteocalcin ELISA | 2016 | https://pubmed.ncbi.nlm.nih.gov/27506449/ | ELISA | Serum | |
| Bone/Renal | Osteocalcin | EIA Kit | Rat | 60-1505 | Rat Osteocalcin ELISA | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27695051 | ELISA | Serum | |
| Bone/Renal | PTH | EIA Kit | Mouse | 60-2305 | Mouse PTH 1-84 ELISA | 2017 | https://pubmed.ncbi.nlm.nih.gov/28887454/ | ELISA | Plasma | |
| Bone/Renal | PTH | EIA Kit | Mouse | 60-2305 | Mouse PTH 1-84 ELISA | 2018 | https://pubmed.ncbi.nlm.nih.gov/29381784/ | ELISA | Plasma | |
| Bone/Renal | PTH | EIA Kit | Mouse | 60-2305 | Mouse PTH 1-84 ELISA | 2019 | https://pubmed.ncbi.nlm.nih.gov/30818998/ | ELISA | Serum | |
| Bone/Renal | PTH | EIA Kit | Mouse | 60-2305 | Mouse PTH 1-84 ELISA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31237611/ | ELISA | Serum | |
| Bone/Renal | PTH | EIA Kit | Mouse | 60-2305 | Mouse PTH 1-84 ELISA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31237611/ | ELISA | Urine | |
| Bone/Renal | PTH | EIA Kit | Mouse | 60-2305 | Mouse PTH 1-84 ELISA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31628396/ | ELISA | Plasma | |
| Bone/Renal | PTH | EIA Kit | Mouse | 60-2305 | Mouse PTH 1-84 ELISA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31805212/ | ELISA | Plasma | |
| Bone/Renal | PTH | EIA Kit | Mouse | 60-2305 | Mouse PTH 1-84 ELISA | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23700148 | ELISA | Serum | |
| Bone/Renal | PTH | EIA Kit | Mouse | 60-2305 | Mouse PTH 1-84 ELISA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25858796 | ELISA | Serum | |
| Bone/Renal | PTH | EIA Kit | Mouse | 60-2305 | Mouse PTH 1-84 ELISA | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/26535997 | ELISA | Serum | |
| Bone/Renal | PTH | EIA Kit | Mouse | 60-2305 | Mouse PTH 1-84 ELISA | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/26945509 | ELISA | Serum | |
| Bone/Renal | PTH | EIA Kit | Mouse | 60-2305 | Mouse PTH 1-84 ELISA | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27784318 | ELISA | Serum | |
| Bone/Renal | PTH | EIA Kit | Cell Culture | 60-2500 | Rat PTH ELISA | 2004 | https://www.ncbi.nlm.nih.gov/pubmed/14593085 | ELISA | HEK 293 4.0-7 cells | |
| Bone/Renal | PTH | EIA Kit | Rat | 60-2500 | Rat PTH ELISA | 2007 | https://www.ncbi.nlm.nih.gov/pubmed/17706605 | ELISA | Serum | |
| Bone/Renal | PTH | EIA Kit | Rat | 60-2500 | Rat PTH ELISA | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/24108429 | ELISA | Plasma | |
| Bone/Renal | PTH | EIA Kit | Rat | 60-2500 | Rat PTH ELISA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25858796 | ELISA | Serum | |
| Bone/Renal | PTH | EIA Kit | Rat | 60-2700 | Rat Bioactive PTH ELISA | 2020 | https://pubmed.ncbi.nlm.nih.gov/32853180/ | ELISA | Plasma | |
| Bone/Renal | PTH | EIA Kit | Rat | 60-2700 | Rat Bioactive PTH ELISA | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/24625659 | ELISA | Serum | |
| Bone/Renal | PTH | EIA Kit | Rat | 60-2700 | Rat Bioactive PTH ELISA | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/24652795 | ELISA | Serum | |
| Bone/Renal | PTH | EIA Kit | Rat | 60-2700 | Rat Bioactive PTH ELISA | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/24875663 | ELISA | Serum | |
| Bone/Renal | PTH | EIA Kit | Rat | 60-2700 | Rat Bioactive PTH ELISA | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27136580 | ELISA | Serum | |
| Bone/Renal | PTH | EIA Kit | Rat | 60-2700 | Rat Bioactive PTH ELISA | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27695051 | ELISA | Serum | |
| Bone/Renal | PTH | EIA Kit | Human | 60-3000 | Human Bioactive 1-84 ELISA | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21565884 | ELISA | Serum | |
| Bone/Renal | PTH | EIA Kit | Human | 60-3100 | Human PTH ELISA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31881044/ | ELISA | Serum | |
| Bone/Renal | PTH | EIA Kit | Human | 60-3100 | Human PTH ELISA | 2020 | https://pubmed.ncbi.nlm.nih.gov/32694162/ | ELISA | Plasma | Chronic Kidney Disease |
| Bone/Renal | PTH | EIA Kit | Human | 60-3100 | Human PTH ELISA | 2005 | https://www.ncbi.nlm.nih.gov/pubmed/15917335 | ELISA | Serum | |
| Bone/Renal | PTH | EIA Kit | Human | 60-3100 | Human PTH ELISA | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22052943 | ELISA | Plasma | |
| Bone/Renal | PTH | EIA Kit | Human | 60-3100 | Human PTH ELISA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25774916 | ELISA | Plasma | |
| Bone/Renal | PTH | EIA Kit | Human | 60-3100 | Human PTH ELISA | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27784318 | ELISA | Plasma | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2010 | https://pubmed.ncbi.nlm.nih.gov/20707671/ | ELISA | Plasma | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2010 | https://pubmed.ncbi.nlm.nih.gov/20707671/ | ELISA | Serum | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2018 | https://pubmed.ncbi.nlm.nih.gov/29980527/ | ELISA | Plasma | Diabetes |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31058117/ | ELISA | Plasma | Hypertension (Children) |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31170159/ | ELISA | Plasma | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2020 | https://pubmed.ncbi.nlm.nih.gov/32694162/ | ELISA | Plasma | Chronic Kidney Disease |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2005 | https://www.ncbi.nlm.nih.gov/pubmed/15917335 | ELISA | Serum | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/19564163 | ELISA | Plasma | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/19837926 | ELISA | HEK293 cells | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/19837926 | ELISA | Plasma | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2010 | https://www.ncbi.nlm.nih.gov/pubmed/19965919 | ELISA | Plasma | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2010 | https://www.ncbi.nlm.nih.gov/pubmed/20157196 | ELISA | Plasma | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/22035861 | ELISA | Serum | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22052943 | ELISA | Plasma | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22311343 | ELISA | Serum | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22567137 | ELISA | Serum | Chronic Kidney Disease |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/22648001 | ELISA | Plasma | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22689697 | ELISA | Plasma | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23246670 | ELISA | Plasma | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23841978 | ELISA | Plasma | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/24119158 | ELISA | Serum | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/24258305 | ELISA | Plasma | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/24578336 | ELISA | Plasma | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2018 | https://www.ncbi.nlm.nih.gov/pubmed/24748388 | ELISA | Plasma | Acute Coronary Syndrome |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/25221676 | ELISA | Plasma | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25774916 | ELISA | Plasma | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/26481743 | ELISA | Plasma | MHD |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27171378 | ELISA | Plasma | Acute Coronary Syndrome |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27529627 | ELISA | Plasma | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27784318 | ELISA | Plasma | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27861335 | ELISA | Plasma | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2018 | https://www.ncbi.nlm.nih.gov/pubmed/29696242 | ELISA | Plasma | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2018 | https://www.ncbi.nlm.nih.gov/pubmed/30197987 | ELISA | Serum | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2018 | https://www.ncbi.nlm.nih.gov/pubmed/30620003 | ELISA | Plasma | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6100 | Human FGF-23 C-Term ELISA | 2019 | https://www.ncbi.nlm.nih.gov/pubmed/30726771 | ELISA | Serum | Hypoparathyroidism |
| Bone/Renal | FGF-23 | EIA Kit | Mouse | 60-6300 | Mouse/Rat FGF-23 C-Term ELISA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31237611/ | ELISA | Serum | |
| Bone/Renal | FGF-23 | EIA Kit | Mouse | 60-6300 | Mouse/Rat FGF-23 C-Term ELISA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31237611/ | ELISA | Urine | |
| Bone/Renal | FGF-23 | EIA Kit | Mouse | 60-6300 | Mouse/Rat FGF-23 C-Term ELISA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31628396/ | ELISA | Plasma | |
| Bone/Renal | FGF-23 | EIA Kit | Mouse | 60-6300 | Mouse/Rat FGF-23 C-Term ELISA | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23700148 | ELISA | Serum | |
| Bone/Renal | FGF-23 | EIA Kit | Rat | 60-6300 | Mouse/Rat FGF-23 C-Term ELISA | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/24875663 | ELISA | Serum | |
| Bone/Renal | FGF-23 | EIA Kit | Mouse | 60-6300 | Mouse/Rat FGF-23 C-Term ELISA | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/26535997 | ELISA | Serum | |
| Bone/Renal | FGF-23 | EIA Kit | Mouse | 60-6300 | Mouse/Rat FGF-23 C-Term ELISA | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27784318 | ELISA | Serum | |
| Bone/Renal | FGF-23 | EIA Kit | Mouse | 60-6300 | Mouse/Rat FGF-23 C-Term ELISA | 2018 | https://www.ncbi.nlm.nih.gov/pubmed/29338760 | ELISA | Serum | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6600 | Human FGF-23 (Intact) ELISA | 2010 | https://pubmed.ncbi.nlm.nih.gov/20707671/ | ELISA | Plasma | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6600 | Human FGF-23 (Intact) ELISA | 2010 | https://pubmed.ncbi.nlm.nih.gov/20707671/ | ELISA | Serum | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6600 | Human FGF-23 (Intact) ELISA | 2020 | https://pubmed.ncbi.nlm.nih.gov/32694162/ | ELISA | Plasma | Chronic Kidney Disease |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6600 | Human FGF-23 (Intact) ELISA | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/19837926 | ELISA | Plasma | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6600 | Human FGF-23 (Intact) ELISA | 2010 | https://www.ncbi.nlm.nih.gov/pubmed/20157196 | ELISA | Plasma | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6600 | Human FGF-23 (Intact) ELISA | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22567137 | ELISA | Serum | Chronic Kidney Disease |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6600 | Human FGF-23 (Intact) ELISA | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22689697 | ELISA | Plasma | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6600 | Human FGF-23 (Intact) ELISA | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/24578336 | ELISA | Plasma | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6600 | Human FGF-23 (Intact) ELISA | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27176000 | ELISA | Plasma | HIV |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6600 | Human FGF-23 (Intact) ELISA | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27529627 | ELISA | Plasma | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6600 | Human FGF-23 (Intact) ELISA | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27784318 | ELISA | Plasma | |
| Bone/Renal | FGF-23 | EIA Kit | Human | 60-6600 | Human FGF-23 (Intact) ELISA | 2018 | https://www.ncbi.nlm.nih.gov/pubmed/29726397 | ELISA | Plasma | Hypoparathyroidism |
| Bone/Renal | FGF-23 | EIA Kit | Mouse | 60-6800 | Mouse/Rat FGF-23 (Intact) ELISA | 2017 | https://pubmed.ncbi.nlm.nih.gov/28887454/ | ELISA | Plasma | |
| Bone/Renal | FGF-23 | EIA Kit | Mouse | 60-6800 | Mouse/Rat FGF-23 (Intact) ELISA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31237611/ | ELISA | Serum | |
| Bone/Renal | FGF-23 | EIA Kit | Mouse | 60-6800 | Mouse/Rat FGF-23 (Intact) ELISA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31237611/ | ELISA | Urine | |
| Bone/Renal | FGF-23 | EIA Kit | Mouse | 60-6800 | Mouse/Rat FGF-23 (Intact) ELISA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31484825/ | ELISA | Serum | |
| Bone/Renal | FGF-23 | EIA Kit | Mouse | 60-6800 | Mouse/Rat FGF-23 (Intact) ELISA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31628396/ | ELISA | Plasma | |
| Bone/Renal | FGF-23 | EIA Kit | Mouse | 60-6800 | Mouse/Rat FGF-23 (Intact) ELISA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31805212/ | ELISA | Plasma | |
| Bone/Renal | FGF-23 | EIA Kit | Rat | 60-6800 | Mouse/Rat FGF-23 (Intact) ELISA | 2020 | https://pubmed.ncbi.nlm.nih.gov/32853180/ | ELISA | Plasma | |
| Bone/Renal | Osteocalcin | EIA Kit | Human | 8001 | Osteocalcin EIA | 2010 | https://pubmed.ncbi.nlm.nih.gov/19960194/ | ELISA | Mesenchymal Cells | |
| Bone/Renal | Osteocalcin | EIA Kit | Human | 8001 | Osteocalcin EIA | 2012 | https://pubmed.ncbi.nlm.nih.gov/22505457/ | ELISA | Serum | |
| Bone/Renal | Osteocalcin | EIA Kit | Human | 8001 | Osteocalcin EIA | 2015 | https://pubmed.ncbi.nlm.nih.gov/26236583/ | ELISA | Serum | Obesity, children |
| Bone/Renal | Osteocalcin | EIA Kit | Human | 8001 | Osteocalcin EIA | 2016 | https://pubmed.ncbi.nlm.nih.gov/26886633/ | ELISA | Serum | |
| Bone/Renal | Osteocalcin | EIA Kit | Human | 8001 | Osteocalcin EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31357402/ | ELISA | Urine | |
| Bone/Renal | Osteocalcin | EIA Kit | Mouse | 8001 | Osteocalcin EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31628396/ | ELISA | Plasma | |
| Bone/Renal | Osteocalcin | EIA Kit | Human | 8001 | Osteocalcin EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31881044/ | ELISA | Serum | |
| Bone/Renal | CICP | EIA Kit | Human | 8005 | CICP EIA | 2006 | https://pubmed.ncbi.nlm.nih.gov/17156456/ | ELISA | Osteoblasts | |
| Bone/Renal | CICP | EIA Kit | Human | 8005 | CICP EIA | 2010 | https://pubmed.ncbi.nlm.nih.gov/19960194/ | ELISA | Mesenchymal Cells | |
| Bone/Renal | CICP | EIA Kit | N/A | 8005 | CICP EIA | 2011 | https://pubmed.ncbi.nlm.nih.gov/21721839/ | ELISA | Nafion | |
| Bone/Renal | CICP | EIA Kit | Human | 8005 | CICP EIA | 2012 | https://pubmed.ncbi.nlm.nih.gov/22389002/ | ELISA | Serum | |
| Bone/Renal | CICP | EIA Kit | Human | 8005 | CICP EIA | 2012 | https://pubmed.ncbi.nlm.nih.gov/22628530/ | ELISA | Plasma | |
| Bone/Renal | CICP | EIA Kit | Human | 8005 | CICP EIA | 2014 | https://pubmed.ncbi.nlm.nih.gov/24565955/ | ELISA | Serum | |
| Bone/Renal | CICP | EIA Kit | Human | 8005 | CICP EIA | 2014 | https://pubmed.ncbi.nlm.nih.gov/25027750/ | ELISA | Fibroblasts | |
| Bone/Renal | CICP | EIA Kit | Rhesus Monkey | 8005 | CICP EIA | 2015 | https://pubmed.ncbi.nlm.nih.gov/25246534/ | ELISA | Serum | |
| Bone/Renal | CICP | EIA Kit | Human | 8005 | CICP EIA | 2015 | https://pubmed.ncbi.nlm.nih.gov/25457675/ | ELISA | Skin Tissue | |
| Bone/Renal | CICP | EIA Kit | Human | 8005 | CICP EIA | 2015 | https://pubmed.ncbi.nlm.nih.gov/26214688/ | ELISA | Liver Myofibroblasts | HCV Infected |
| Bone/Renal | CICP | EIA Kit | Rabbit | 8005 | CICP EIA | 2016 | https://pubmed.ncbi.nlm.nih.gov/26416658/ | ELISA | Plasma | |
| Bone/Renal | CICP | EIA Kit | Human | 8005 | CICP EIA | 2016 | https://pubmed.ncbi.nlm.nih.gov/26886633/ | ELISA | Serum | |
| Bone/Renal | CICP | EIA Kit | Human | 8005 | CICP EIA | 2017 | https://pubmed.ncbi.nlm.nih.gov/28782046/ | ELISA | Plasma | HIV |
| Bone/Renal | CICP | EIA Kit | Human | 8005 | CICP EIA | 2011 | https://pubmed.ncbi.nlm.nih.gov/28824140/ | ELISA | Osteoblasts | |
| Bone/Renal | CICP | EIA Kit | Human | 8005 | CICP EIA | 2017 | https://pubmed.ncbi.nlm.nih.gov/28851983/ | ELISA | Peripheral blood mononuclear cells | |
| Bone/Renal | CICP | EIA Kit | Human | 8005 | CICP EIA | 2018 | https://pubmed.ncbi.nlm.nih.gov/31298998/ | ELISA | Serum | |
| Bone/Renal | CICP | EIA Kit | Human | 8005 | CICP EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31652962/ | ELISA | Chondrocytes | |
| Bone/Renal | DPD | EIA Kit | Mouse | 8007 | DPD EIA | 2011 | https://pubmed.ncbi.nlm.nih.gov/21159123/ | ELISA | Urine | |
| Bone/Renal | DPD | EIA Kit | Human | 8007 | DPD EIA | 2012 | https://pubmed.ncbi.nlm.nih.gov/22905997/ | ELISA | Urine | Hematopoietic cell transplantation |
| Bone/Renal | DPD | EIA Kit | Human | 8007 | DPD EIA | 2014 | https://pubmed.ncbi.nlm.nih.gov/24447701/ | ELISA | Serum | |
| Bone/Renal | DPD | EIA Kit | Mouse | 8007 | DPD EIA | 2014 | https://pubmed.ncbi.nlm.nih.gov/24652796/ | ELISA | Urine | |
| Bone/Renal | DPD | EIA Kit | Human | 8007 | DPD EIA | 2014 | https://pubmed.ncbi.nlm.nih.gov/25096868/ | ELISA | Urine | Mucopolysaccharidosis Types I, II, and VI, children |
| Bone/Renal | DPD | EIA Kit | Rabbit | 8007 | DPD EIA | 2016 | https://pubmed.ncbi.nlm.nih.gov/26416658/ | ELISA | Urine | |
| Bone/Renal | DPD | EIA Kit | Rat | 8007 | DPD EIA | 2016 | https://pubmed.ncbi.nlm.nih.gov/27136580/ | ELISA | Urine | |
| Bone/Renal | DPD | EIA Kit | Rat | 8007 | DPD EIA | 2016 | https://pubmed.ncbi.nlm.nih.gov/27506449/ | ELISA | Urine | |
| Bone/Renal | DPD | EIA Kit | Mouse | 8007 | DPD EIA | 2017 | https://pubmed.ncbi.nlm.nih.gov/28744019/ | ELISA | Urine | |
| Bone/Renal | DPD | EIA Kit | Mouse | 8007 | DPD EIA | 2017 | https://pubmed.ncbi.nlm.nih.gov/28887454/ | ELISA | Urine | |
| Bone/Renal | DPD | EIA Kit | Mouse | 8007 | DPD EIA | 2018 | https://pubmed.ncbi.nlm.nih.gov/29736604/ | ELISA | Urine | |
| Bone/Renal | DPD | EIA Kit | Rat | 8007 | DPD EIA | 2018 | https://pubmed.ncbi.nlm.nih.gov/30150931/ | ELISA | Urine | |
| Bone/Renal | DPD | EIA Kit | Mouse | 8007 | DPD EIA | 2018 | https://pubmed.ncbi.nlm.nih.gov/30297393/ | ELISA | Urine | |
| Bone/Renal | DPD | EIA Kit | Mouse | 8007 | DPD EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/30632962/ | ELISA | Urine | |
| Bone/Renal | DPD | EIA Kit | Mouse | 8007 | DPD EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31628396/ | ELISA | Urine | |
| Bone/Renal | Creatinine | EIA Kit | Human | 8009 | Creatinine EIA | 2014 | https://pubmed.ncbi.nlm.nih.gov/25096868/ | ELISA | Urine | Mucopolysaccharidosis Types I, II, and VI, children |
| Bone/Renal | Creatinine | EIA Kit | Rabbit | 8009 | Creatinine EIA | 2016 | https://pubmed.ncbi.nlm.nih.gov/26416658/ | ELISA | Urine | |
| Bone/Renal | Creatinine | EIA Kit | Mouse | 8009 | Creatinine EIA | 2018 | https://pubmed.ncbi.nlm.nih.gov/30297393/ | ELISA | Urine | |
| Bone/Renal | Creatinine | EIA Kit | Mouse | 8009 | Creatinine EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/30632962/ | ELISA | Urine | |
| Bone/Renal | Creatinine | EIA Kit | Human | 8009 | Creatinine EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31357402/ | ELISA | Serum | |
| Bone/Renal | PYD | EIA Kit | Mouse | 8010 | PYD EIA | 2009 | https://pubmed.ncbi.nlm.nih.gov/20003498/ | ELISA | Urine | |
| Bone/Renal | PYD | EIA Kit | Mouse | 8010 | PYD EIA | 2011 | https://pubmed.ncbi.nlm.nih.gov/21538012/ | ELISA | Artery Tissue | |
| Bone/Renal | PYD | EIA Kit | Human | 8010 | PYD EIA | 2012 | https://pubmed.ncbi.nlm.nih.gov/22905997/ | ELISA | Urine | Hematopoietic cell transplantation |
| Bone/Renal | PYD | EIA Kit | Human | 8010 | PYD EIA | 2014 | https://pubmed.ncbi.nlm.nih.gov/25096868/ | ELISA | Urine | Mucopolysaccharidosis Types I, II, and VI, children |
| Bone/Renal | PYD | EIA Kit | Rat | 8010 | PYD EIA | 2016 | https://pubmed.ncbi.nlm.nih.gov/27107489/ | ELISA | Heart Tissue | |
| Bone/Renal | PYD | EIA Kit | Mouse | 8010 | PYD EIA | 2016 | https://pubmed.ncbi.nlm.nih.gov/27115490/ | ELISA | Urine | |
| Bone/Renal | PYD | EIA Kit | Human | 8010 | PYD EIA | 2018 | https://pubmed.ncbi.nlm.nih.gov/29988126/ | ELISA | Lung Tissue | |
| Bone/Renal | BAP | EIA Kit | Human | 8012 | BAP EIA | 2010 | https://pubmed.ncbi.nlm.nih.gov/19965927/ | ELISA | Serum | |
| Bone/Renal | BAP | EIA Kit | Human | 8012 | BAP EIA | 2010 | https://pubmed.ncbi.nlm.nih.gov/20205166/ | ELISA | Serum | |
| Bone/Renal | BAP | EIA Kit | Porcine | 8012 | BAP EIA | 2012 | https://pubmed.ncbi.nlm.nih.gov/22578071/ | ELISA | Serum | |
| Bone/Renal | BAP | EIA Kit | Human | 8012 | BAP EIA | 2013 | https://pubmed.ncbi.nlm.nih.gov/24013463/ | ELISA | Plasma | Women Using Hormonal Contraceptives |
| Bone/Renal | BAP | EIA Kit | Human | 8012 | BAP EIA | 2014 | https://pubmed.ncbi.nlm.nih.gov/24447701/ | ELISA | Serum | |
| Bone/Renal | BAP | EIA Kit | Human | 8012 | BAP EIA | 2014 | https://pubmed.ncbi.nlm.nih.gov/24565955/ | ELISA | Serum | |
| Bone/Renal | BAP | EIA Kit | Human | 8012 | BAP EIA | 2014 | https://pubmed.ncbi.nlm.nih.gov/25096868/ | ELISA | Serum | Mucopolysaccharidosis Types I, II, and VI in children |
| Bone/Renal | BAP | EIA Kit | Human | 8012 | BAP EIA | 2014 | https://pubmed.ncbi.nlm.nih.gov/25166750/ | ELISA | Serum | Cholecalciferol |
| Bone/Renal | BAP | EIA Kit | Human | 8012 | BAP EIA | 2015 | https://pubmed.ncbi.nlm.nih.gov/25311107/ | ELISA | Plasma | |
| Bone/Renal | BAP | EIA Kit | Human | 8012 | BAP EIA | 2015 | https://pubmed.ncbi.nlm.nih.gov/25470722/ | ELISA | Serum | Premenopausal Women w/wo Type 1 Diabetes |
| Bone/Renal | BAP | EIA Kit | Human | 8012 | BAP EIA | 2015 | https://pubmed.ncbi.nlm.nih.gov/26236583/ | ELISA | Serum | Obesity, children |
| Bone/Renal | BAP | EIA Kit | Human | 8012 | BAP EIA | 2015 | https://pubmed.ncbi.nlm.nih.gov/26664272/ | ELISA | Serum | Middle-Aged Premenopausal Women |
| Bone/Renal | BAP | EIA Kit | Human | 8012 | BAP EIA | 2016 | https://pubmed.ncbi.nlm.nih.gov/27408764/ | ELISA | Serum | Postmenopausal women |
| Bone/Renal | BAP | EIA Kit | Human | 8012 | BAP EIA | 2017 | https://pubmed.ncbi.nlm.nih.gov/27915435/ | ELISA | Serum | |
| Bone/Renal | BAP | EIA Kit | Cynomolgus Monkey | 8012 | BAP EIA | 2018 | https://pubmed.ncbi.nlm.nih.gov/29260289/ | ELISA | Serum | |
| Bone/Renal | BAP | EIA Kit | Human | 8012 | BAP EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/30862350/ | ELISA | Serum | Chronic Kidney Disease |
| Bone/Renal | BAP | EIA Kit | Human | 8012 | BAP EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31086410/ | ELISA | Serum | |
| Bone/Renal | BAP | EIA Kit | Human | 8012 | BAP EIA | 2018 | https://pubmed.ncbi.nlm.nih.gov/31298998/ | ELISA | Serum | |
| Bone/Renal | BAP | EIA Kit | Human | 8012 | BAP EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31357402/ | ELISA | Serum | |
| Bone/Renal | BAP | EIA Kit | Human | 8012 | BAP EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/32213826/ | ELISA | Serum | Older African American Women |
| Bone/Renal | PYD | EIA Kit | Mouse | 8019 | Serum PYD EIA | 2011 | https://pubmed.ncbi.nlm.nih.gov/21123822/ | ELISA | Serum | |
| Bone/Renal | PYD | EIA Kit | Mouse | 8019 | Serum PYD EIA | 2013 | https://pubmed.ncbi.nlm.nih.gov/23583750/ | ELISA | Serum | |
| Bone/Renal | PYD | EIA Kit | Mouse | 8019 | Serum PYD EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/23649480/ | ELISA | Serum | |
| Bone/Renal | PYD | EIA Kit | Human | 8019 | Serum PYD EIA | 2014 | https://pubmed.ncbi.nlm.nih.gov/24565955/ | ELISA | Serum | |
| Bone/Renal | PYD | EIA Kit | Mouse | 8019 | Serum PYD EIA | 2014 | https://pubmed.ncbi.nlm.nih.gov/24741116/ | ELISA | Lung Tissue | |
| Bone/Renal | PYD | EIA Kit | Rat | 8019 | Serum PYD EIA | 2015 | https://pubmed.ncbi.nlm.nih.gov/26582054/ | ELISA | Heart Tissue | |
| Bone/Renal | PYD | EIA Kit | Human | 8019 | Serum PYD EIA | 2016 | https://pubmed.ncbi.nlm.nih.gov/26886633/ | ELISA | Serum | |
| Bone/Renal | PYD | EIA Kit | Human | 8019 | Serum PYD EIA | 2018 | https://pubmed.ncbi.nlm.nih.gov/31298998/ | ELISA | Serum | |
| Bone/Renal | PYD | EIA Kit | Mouse | 8019 | Serum PYD EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/32479501/ | ELISA | Serum | |
| Bone/Renal | TRAP5b | EIA Kit | Mouse | 8033 | TRAP5b EIA | 2011 | https://pubmed.ncbi.nlm.nih.gov/21123822/ | ELISA | Serum | |
| Bone/Renal | TRAP5b | EIA Kit | Human | 8033 | TRAP5b EIA | 2012 | https://pubmed.ncbi.nlm.nih.gov/22505457/ | ELISA | Serum | |
| Bone/Renal | TRAP5b | EIA Kit | Human | 8033 | TRAP5b EIA | 2012 | https://pubmed.ncbi.nlm.nih.gov/22689860/ | ELISA | Multiple Myeloma cells | |
| Bone/Renal | TRAP5b | EIA Kit | Human | 8033 | TRAP5b EIA | 2013 | https://pubmed.ncbi.nlm.nih.gov/23924795/ | ELISA | Monocytes | |
| Bone/Renal | TRAP5b | EIA Kit | Human | 8033 | TRAP5b EIA | 2015 | https://pubmed.ncbi.nlm.nih.gov/25470722/ | ELISA | Serum | Premenopausal Women w/wo Type 1 Diabetes |
| Bone/Renal | TRAP5b | EIA Kit | Human | 8033 | TRAP5b EIA | 2015 | https://pubmed.ncbi.nlm.nih.gov/26664272/ | ELISA | Serum | Middle-Aged Premenopausal Women |
| Bone/Renal | TRAP5b | EIA Kit | Human | 8033 | TRAP5b EIA | 2017 | https://pubmed.ncbi.nlm.nih.gov/27915435/ | ELISA | Serum | |
| Bone/Renal | TRAP5b | EIA Kit | Human | 8033 | TRAP5b EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/29998134/ | ELISA | Serum | Osteochondritis Dissecans |
| Bone/Renal | TRAP5b | EIA Kit | Human | 8033 | TRAP5b EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/30862350/ | ELISA | Serum | Chronic Kidney Disease |
| Bone/Renal | TRAP5b | EIA Kit | Human | 8033 | TRAP5b EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/30889272/ | ELISA | Serum | Albers- Schönberg disease |
| Bone/Renal | TRAP5b | EIA Kit | Human | 8033 | TRAP5b EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31881044/ | ELISA | Serum | |
| Complement System | C1q | EIA Kit | Human | A001 | CIC-C1q EIA | 2017 | https://pubmed.ncbi.nlm.nih.gov/28782046/ | ELISA | Plasma | HIV |
| Complement System | C1q | EIA Kit | Human | A001 | CIC-C1q EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31897428/ | ELISA | Serum | |
| Complement System | C1q | EIA Kit | Human | A001 | CIC-C1q EIA | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/19707565 | ELISA | Plasma | Dengue |
| Complement System | C1q | EIA Kit | Human | A001 | CIC-C1q EIA | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21734131 | ELISA | Plasma | Lymphatic filariasis |
| Complement System | C1q | EIA Kit | Human | A001 | CIC-C1q EIA | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21860370 | ELISA | Serum | |
| Complement System | C1q | EIA Kit | Human | A001 | CIC-C1q EIA | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22070392 | ELISA | Synovial fluid | |
| Complement System | C1q | EIA Kit | Human | A001 | CIC-C1q EIA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/23706313 | ELISA | Plasma | |
| Complement System | C1q | EIA Kit | Human | A001 | CIC-C1q EIA | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/25092568 | ELISA | Serum | |
| Complement System | C1q | EIA Kit | Human | A001 | CIC-C1q EIA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/26578679 | ELISA | Serum | Malaria |
| Complement System | C3d | EIA Kit | Human | A002 | CIC-Raji Cell Replacement EIA | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22837639 | ELISA | Serum | |
| Complement System | C3d | EIA Kit | Human | A002 | CIC-Raji Cell Replacement EIA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/23706313 | ELISA | Plasma | |
| Complement System | iC3b | EIA Kit | Human | A006 | iC3b EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/32717972/ | ELISA | Plasma | |
| Complement System | iC3b | EIA Kit | Human | A006 | iC3b EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34338598/ | ELISA | Serum | Aspergillus incubated |
| Complement System | iC3b | EIA Kit | Human | A006 | iC3b EIA | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/19029031 | ELISA | Serum | |
| Complement System | iC3b | EIA Kit | Human | A006 | iC3b EIA | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21675859 | ELISA | Plasma | |
| Complement System | iC3b | EIA Kit | Human | A006 | iC3b EIA | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23741476 | ELISA | CSF | |
| Complement System | iC3b | EIA Kit | Human | A006 | iC3b EIA | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/24448198 | ELISA | Serum | Trauma |
| Complement System | iC3b | EIA Kit | Human | A006 | iC3b EIA | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/24983375 | ELISA | Serum | HCV |
| Complement System | iC3b | EIA Kit | Human | A006 | iC3b EIA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25660530 | ELISA | Plasma | |
| Complement System | iC3b | EIA Kit | Human | A006 | iC3b EIA | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/25960946 | ELISA | CSF | Listeria meningitis |
| Complement System | iC3b | EIA Kit | Human | A006 | iC3b EIA | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/29209332 | ELISA | Serum | |
| Complement System | iC3b | EIA Kit | Human | A006 | iC3b EIA | 2018 | https://www.ncbi.nlm.nih.gov/pubmed/29782502 | ELISA | Plasma | Age-Related Macular Degeneration |
| Complement System | iC3b | EIA Kit | Human | A006 | iC3b EIA | 2018 | https://www.ncbi.nlm.nih.gov/pubmed/29782502 | ELISA | Plasma | Alzheimer's Disease |
| Complement System | C4d | EIA Kit | Human | A009 | C4d Fragment EIA | 2008 | https://pubmed.ncbi.nlm.nih.gov/19005576/ | ELISA | Serum | Floridoside incubated |
| Complement System | C4d | EIA Kit | Human | A009 | C4d Fragment EIA | 2017 | https://pubmed.ncbi.nlm.nih.gov/28604720/ | ELISA | Serum | |
| Complement System | C4d | EIA Kit | Human | A009 | C4d Fragment EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31215772/ | ELISA | Plasma | ANCA-AAV |
| Complement System | C4d | EIA Kit | Human | A009 | C4d Fragment EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31730685/ | ELISA | Plasma | aHUS |
| Complement System | C4d | EIA Kit | Human | A009 | C4d Fragment EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/32569286/ | ELISA | Plasma | FSGS |
| Complement System | C4d | EIA Kit | Human | A009 | C4d Fragment EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/32569286/ | ELISA | Serum | FSGS |
| Complement System | C4d | EIA Kit | Mouse | A009 | C4d Fragment EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/32730229/ | ELISA | Plasma | |
| Complement System | C4d | EIA Kit | Human | A009 | C4d Fragment EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/32750037/ | ELISA | Bronchoalveolar lavage | Lung transplant |
| Complement System | C4d | EIA Kit | Human | A009 | C4d Fragment EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/33170371/ | ELISA | Serum | Lupus Nephritis, Thrombotic Microangiopathy |
| Complement System | C4d | EIA Kit | Human | A009 | C4d Fragment EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/33170371/ | ELISA | Urine | Lupus Nephritis, Thrombotic Microangiopathy |
| Complement System | C4d | EIA Kit | Human | A009 | C4d Fragment EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34381048/ | ELISA | Plasma | |
| Complement System | C4d | EIA Kit | Human | A009 | C4d Fragment EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34732467/ | ELISA | Plasma | |
| Complement System | C4d | EIA Kit | Human | A009 | C4d Fragment EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35034207/ | ELISA | Plasma | COVID-19 |
| Complement System | C4d | EIA Kit | Human | A009 | C4d Fragment EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35034207/ | ELISA | Serum | COVID-19 |
| Complement System | C4d | EIA Kit | Human | A009 | C4d Fragment EIA | 2010 | https://www.ncbi.nlm.nih.gov/pubmed/20877360 | ELISA | Plasma | Breast Cancer |
| Complement System | C4d | EIA Kit | Human | A009 | C4d Fragment EIA | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21675859 | ELISA | Plasma | |
| Complement System | C4d | EIA Kit | Human | A009 | C4d Fragment EIA | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22583529 | ELISA | Plasma | |
| Complement System | C4d | EIA Kit | Human | A009 | C4d Fragment EIA | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/24099708 | ELISA | Plasma | |
| Complement System | C4d | EIA Kit | Human | A009 | C4d Fragment EIA | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/25425420 | ELISA | Serum | SPIO nanoworms |
| Complement System | C4d | EIA Kit | Human | A009 | C4d Fragment EIA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25677399 | ELISA | Plasma | Stx-HUS |
| Complement System | C4d | EIA Kit | Human | A009 | C4d Fragment EIA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25994214 | ELISA | Plasma | |
| Complement System | C4d | EIA Kit | Human | A009 | C4d Fragment EIA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/26374997 | ELISA | Serum | Nanoparticles incubated |
| Complement System | C4d | EIA Kit | Human | A009 | C4d Fragment EIA | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/26736041 | ELISA | Serum | |
| Complement System | C4d | EIA Kit | Human | A009 | C4d Fragment EIA | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27777575 | ELISA | Serum | |
| Complement System | C4d | EIA Kit | Human | A009 | C4d Fragment EIA | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28803115 | ELISA | Serum | |
| Complement System | C4d | EIA Kit | Human | A009 | C4d Fragment EIA | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/29141676 | ELISA | Plasma | ANCA-AAV |
| Complement System | C4d | EIA Kit | Human | A009 | C4d Fragment EIA | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/29184132 | ELISA | Plasma | |
| Complement System | C4d | EIA Kit | Human | A009 | C4d Fragment EIA | 2020 | https://www.ncbi.nlm.nih.gov/pubmed/32065383 | ELISA | Plasma | Immune‐mediated thrombotic thrombocytopenic purpura |
| Complement System | C4d | EIA Kit | Human | A009 | C4d Fragment EIA | 1995 | https://www.ncbi.nlm.nih.gov/pubmed/7554454 | ELISA | Plasma | Sickel Cell Anemia |
| Complement System | C4d | EIA Kit | Human | A009 | C4d Fragment EIA | 1996 | https://www.ncbi.nlm.nih.gov/pubmed/8670328 | ELISA | Plasma | Systemic Lupus Erythematosus |
| Complement System | CH50 | EIA Kit | Human | A018 | CH50 Eq EIA | 2015 | https://pubmed.ncbi.nlm.nih.gov/26248865/ | ELISA | Serum | Acetyl salicylic acid dimer 5,5'-methylenebis(2-acetoxybenzoic acid) (DAS) |
| Complement System | CH50 | EIA Kit | Human | A018 | CH50 Eq EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/32661396/ | ELISA | Serum | HEK 293 Cells incubated |
| Complement System | CH50 | EIA Kit | Human | A018 | CH50 Eq EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/33013880/ | ELISA | Plasma | Severe Traumatic Bleeding |
| Complement System | CH50 | EIA Kit | Cynomolgus Monkey | A018 | CH50 Eq EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/33069749/ | ELISA | Plasma, Serum | T-effector cell agonist (OX40) antibody |
| Complement System | CH50 | EIA Kit | Human | A018 | CH50 Eq EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/33974276/ | ELISA | Serum | COVID-19 |
| Complement System | CH50 | EIA Kit | Human | A018 | CH50 Eq EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35328678/ | ELISA | Serum | Chitosan and Hyaluronic Acid-Based Nanohydrogels |
| Complement System | CH50 | EIA Kit | Human | A018 | CH50 Eq EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35572977/ | ELISA | Serum | COVID-19 |
| Complement System | CH50 | EIA Kit | Human, Primate | A018 | CH50 Eq EIA | 2010 | https://www.ncbi.nlm.nih.gov/pubmed/20375551 | ELISA | Serum | |
| Complement System | CH50 | EIA Kit | Human | A018 | CH50 Eq EIA | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21542928 | ELISA | Serum | |
| Complement System | CH50 | EIA Kit | Human | A018 | CH50 Eq EIA | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21734131 | ELISA | Plasma | Lymphatic filariasis |
| Complement System | CH50 | EIA Kit | Human | A018 | CH50 Eq EIA | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22885994 | ELISA | Serum | Islet Cells |
| Complement System | CH50 | EIA Kit | Human | A018 | CH50 Eq EIA | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23521000 | ELISA | Serum | AamS6 tick protein incubated |
| Complement System | CH50 | EIA Kit | Human | A018 | CH50 Eq EIA | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23625922 | ELISA | Serum | OmCI tick protein incubated |
| Complement System | CH50 | EIA Kit | Human | A018 | CH50 Eq EIA | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27812183 | ELISA | Serum | |
| Complement System | CH50 | EIA Kit | Human | A018 | CH50 Eq EIA | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28516165 | ELISA | Serum | Nanoparticles incubated |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2014 | https://pubmed.ncbi.nlm.nih.gov/25109258/ | ELISA | Plasma | Neuromyelitis optica |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2016 | https://pubmed.ncbi.nlm.nih.gov/27659908/ | ELISA | ARPE-19 Cells | |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2017 | https://pubmed.ncbi.nlm.nih.gov/28640379/ | ELISA | Serum | Diabetes |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2017 | https://pubmed.ncbi.nlm.nih.gov/28986975/ | ELISA | Plasma | Hereditary Angioedema |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2018 | https://pubmed.ncbi.nlm.nih.gov/29925688/ | ELISA | Serum | Microvesicles with heme |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/30601845/ | ELISA | Plasma | Chronic Lymphocytic Leukemia |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/30601845/ | ELISA | Serum | Chronic Lymphocytic Leukemia |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31194090/ | ELISA | Urine | Diabetic nephropathy |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31215772/ | ELISA | Plasma | ANCA-AAV |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31730685/ | ELISA | Plasma | aHUS |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31883521/ | ELISA | CSF | Bacterial meningitis |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31884386/ | ELISA | Plasma | Antibody-mediated endothelial injury |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/32569286/ | ELISA | Plasma | FSGS |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/32569286/ | ELISA | Serum | FSGS |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/32845615/ | ELISA | Serum | SiNP coated proteins |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/32961333/ | ELISA | Plasma | COVID-19 |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/33102961/ | ELISA | Urine | FSGS, MN, IgAN, LN, AAV, or MPGN |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/33139116/ | ELISA | Plasma | COVID-19 |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/33170371/ | ELISA | Serum | Lupus Nephritis, Thrombotic Microangiopathy |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/33170371/ | ELISA | Urine | Lupus Nephritis, Thrombotic Microangiopathy |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/33299378/ | ELISA | Plasma | P-MAPA |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/33324949/ | ELISA | Plasma | Thrombotic Microangiopathy - TA |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/33974276/ | ELISA | Serum | COVID-19 |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34177949/ | ELISA | Glomular Endothelial Cells | Supernatent |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34211499/ | ELISA | Plasma | MPGN |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34245915/ | ELISA | Plasma | C3G |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34245915/ | ELISA | Urine | C3G |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34326846/ | ELISA | Plasma | Thrombotic Microangiopathy - TA |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34381048/ | ELISA | Plasma | |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34381795/ | ELISA | Plasma | Glomerulonephritis |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34386659/ | ELISA | Plasma | Lupus Nephritis |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34491250/ | ELISA | Plasma | Cancer, COVID-19 |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34491250/ | ELISA | Plasma | COVID-19 |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34714369/ | ELISA | Serum | aHUS |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34714369/ | ELISA | Urine | aHUS |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34800432/ | ELISA | Plasma | COVID-19 |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/34852172/ | ELISA | Plasma | aHUS |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/34852172/ | ELISA | Plasma | COVID-19 |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34928990/ | ELISA | Plasma | COVID-19 |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35034207/ | ELISA | Plasma | COVID-19 |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35034207/ | ELISA | Serum | COVID-19 |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35238757/ | ELISA | Plasma | Antiphospholipid syndrome |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35303742/ | ELISA | Plasma | Borrelia hermsii |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35474654/ | ELISA | Plasma | Heat-related illnesses |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35491890/ | ELISA | Serum | Myeloperoxidase-ANCA-associated glomerulonephritis |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35571000/ | ELISA | Urine | AAV, FSGS, IgAN, MN, and LN |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35572977/ | ELISA | Plasma | COVID-19 |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35720304/ | ELISA | Whole Blood | B. jararaca venom |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35743426/ | ELISA | Plasma | Thrombotic Microangiopathy - DI |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35743426/ | ELISA | Plasma | Thrombotic Microangiopathy - DI |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35744709/ | ELISA | Plasma | COVID-19 |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35768780/ | ELISA | Plasma | Hemodialysis |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35846208/ | ELISA | Plasma | Cardiopulmonary bypass |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/36117727/ | ELISA | Plasma | Trauma |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/36143371/ | ELISA | Plasma | COVID-19 |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2023 | https://pubmed.ncbi.nlm.nih.gov/36732701/ | ELISA | Plasma, Serum | Glomerulonephritis |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/19386604 | ELISA | ARPE-19 Cells | |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21542928 | ELISA | Serum | |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21734131 | ELISA | Plasma | Lymphatic filariasis |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22246034 | ELISA | Serum | GEnCs and HUVEC exposed |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22338105 | ELISA | Plasma | |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23537925 | ELISA | Ear Fluid (MEE) | |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23537925 | ELISA | Serum | |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23741476 | ELISA | CSF | |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23964276 | ELISA | Serum | |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/24002570 | ELISA | Plasma | |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/24507657 | ELISA | Serum | |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/24672300 | ELISA | Plasma | Lupus Nephritis |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/25341722 | ELISA | Plasma | C3G |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/25425420 | ELISA | Serum | SPIO nanoworms |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25677399 | ELISA | Plasma | Stx-HUS |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25760458 | ELISA | Serum | Premolis semirufa caterpillar bristle extract |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/25960946 | ELISA | CSF | Listeria meningitis |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25994214 | ELISA | Plasma | |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/26714455 | ELISA | Serum | |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/26780830 | ELISA | Serum | Nanoparticles incubated |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27146825 | ELISA | Serum | |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27293317 | ELISA | Serum | |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27777575 | ELISA | Serum | |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27812183 | ELISA | Plasma | Imprime yeast treated |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28046064 | ELISA | Peritoneal dialysis fluid | |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28672919 | ELISA | Serum | Trauma, newborn brain |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28772696 | ELISA | Serum | |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28803115 | ELISA | Serum | |
| Complement System | sC5b-9 | EIA Kit | Mouse | A020 | SC5b-9 Plus EIA | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28918017 | ELISA | Serum | |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/29141676 | ELISA | Plasma | ANCA-AAV |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2018 | https://www.ncbi.nlm.nih.gov/pubmed/29531170 | ELISA | Serum | Fc activation |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2018 | https://www.ncbi.nlm.nih.gov/pubmed/30116749 | ELISA | Serum | B. lanceolatus venom |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 2020 | https://www.ncbi.nlm.nih.gov/pubmed/32065383 | ELISA | Plasma | Immune‐mediated thrombotic thrombocytopenic purpura |
| Complement System | sC5b-9 | EIA Kit | Human | A020 | SC5b-9 Plus EIA | 1996 | https://www.ncbi.nlm.nih.gov/pubmed/8670328 | ELISA | Plasma | Systemic Lupus Erythematosus |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2016 | https://pubmed.ncbi.nlm.nih.gov/27659908/ | ELISA | ARPE-19 Cells | |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2017 | https://pubmed.ncbi.nlm.nih.gov/28986975/ | ELISA | Plasma | Hereditary Angioedema |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2018 | https://pubmed.ncbi.nlm.nih.gov/29555686/ | ELISA | GMVEC cells, BMVEC cells | |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31215772/ | ELISA | Plasma | ANCA-AAV |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/31672401/ | ELISA | Serum | IVIg formulations |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31883521/ | ELISA | CSF | Bacterial meningitis |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/32569286/ | ELISA | Plasma | FSGS |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/32569286/ | ELISA | Serum | FSGS |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/33123364/ | ELISA | Plasma | COVID-19 |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/33139116/ | ELISA | Plasma | COVID-19 |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/33170371/ | ELISA | Serum | Lupus Nephritis, Thrombotic Microangiopathy |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/33170371/ | ELISA | Urine | Lupus Nephritis, Thrombotic Microangiopathy |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/33974276/ | ELISA | Serum | COVID-19 |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34245915/ | ELISA | Plasma | C3G |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34245915/ | ELISA | Urine | C3G |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34326846/ | ELISA | Plasma | Thrombotic Microangiopathy - TA |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34381048/ | ELISA | Plasma | |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34386659/ | ELISA | Plasma | Lupus Nephritis |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34491250/ | ELISA | Plasma | Cancer, COVID-19 |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34491250/ | ELISA | Plasma | COVID-19 |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/34852172/ | ELISA | Plasma | aHUS |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/34852172/ | ELISA | Plasma | COVID-19 |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34899737/ | ELISA | Serum | |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35034207/ | ELISA | Plasma | COVID-19 |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35034207/ | ELISA | Serum | COVID-19 |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35238757/ | ELISA | Plasma | Antiphospholipid syndrome |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35474654/ | ELISA | Plasma | Heat-related illnesses |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35491890/ | ELISA | Serum | Myeloperoxidase-ANCA-associated glomerulonephritis |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35571000/ | ELISA | Urine | AAV, FSGS, IgAN, MN, and LN |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35768780/ | ELISA | Plasma | Hemodialysis |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35958553/ | ELISA | Serum | CipA |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2023 | https://pubmed.ncbi.nlm.nih.gov/36732701/ | ELISA | Plasma, Serum | Glomerulonephritis |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2023 | https://pubmed.ncbi.nlm.nih.gov/36797757/ | ELISA | Plasma | Sepsis |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21878570 | ELISA | Serum | |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21915248 | ELISA | Fibroblasts | |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22246034 | ELISA | Serum | GEnCs and HUVEC exposed |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23537925 | ELISA | Ear Fluid (MEE) | |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23537925 | ELISA | Serum | |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23741476 | ELISA | CSF | |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/24672300 | ELISA | Plasma | Lupus Nephritis |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/24854857 | ELISA | Plasma | |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/25341722 | ELISA | Plasma | C3G |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25658605 | ELISA | Plasma | |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/25960946 | ELISA | CSF | Listeria meningitis |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25994214 | ELISA | Plasma | |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/26579969 | ELISA | Serum | Porcine articular chondrocytes |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/26654922 | ELISA | Plasma | |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/26714455 | ELISA | Serum | |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27590476 | ELISA | Plasma | |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27777575 | ELISA | Serum | |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27812183 | ELISA | Plasma | Imprime yeast treated |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27918307 | ELISA | Aqueous humour | |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28672919 | ELISA | Serum | Trauma, newborn brain |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/29107969 | ELISA | Plasma | |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/29141676 | ELISA | Plasma | ANCA-AAV |
| Complement System | C5a | EIA Kit | Human | A021 | C5a EIA | 2018 | https://www.ncbi.nlm.nih.gov/pubmed/29531170 | ELISA | Serum | Fc activation |
| Complement System | Bb | EIA Kit | Cynomolgus Monkey | A027 | Bb Plus Fragment EIA | 2002 | https://pubmed.ncbi.nlm.nih.gov/12469940/ | ELISA | Serum | |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31194090/ | ELISA | Urine | Diabetic nephropathy |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31215772/ | ELISA | Plasma | ANCA-AAV |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/31672401/ | ELISA | Serum | IVIg formulations |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31730685/ | ELISA | Plasma | aHUS |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/32569286/ | ELISA | Plasma | FSGS |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/32569286/ | ELISA | Serum | FSGS |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/32845615/ | ELISA | Serum | SiNP coated proteins |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/33974276/ | ELISA | Serum | COVID-19 |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34245915/ | ELISA | Plasma | C3G |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34245915/ | ELISA | Urine | C3G |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34289657/ | ELISA | Serum | COVID-19 |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34376699/ | ELISA | Plasma | |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34381048/ | ELISA | Plasma | |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35034207/ | ELISA | Plasma | COVID-19 |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35034207/ | ELISA | Serum | COVID-19 |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35571000/ | ELISA | Urine | AAV, FSGS, IgAN, MN, and LN |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35846208/ | ELISA | Plasma | Cardiopulmonary bypass |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/36117727/ | ELISA | Plasma | Trauma |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2000 | https://www.ncbi.nlm.nih.gov/pubmed/10725071 | ELISA | Plasma | Rheumatoid Arthritis |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 1992 | https://www.ncbi.nlm.nih.gov/pubmed/1418018 | ELISA | Plasma | Systemic Lupus Erythematosus |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21675859 | ELISA | Plasma | |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21734131 | ELISA | Plasma | Lymphatic filariasis |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22338105 | ELISA | Plasma | |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22457620 | ELISA | Synovial fluid | |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/24002570 | ELISA | Plasma | |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/24099708 | ELISA | Plasma | |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/24672300 | ELISA | Plasma | Lupus Nephritis |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/25341722 | ELISA | Plasma | C3G |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/25425420 | ELISA | Serum | SPIO nanoworms |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25604034 | ELISA | Umbillical cord blood | |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25677399 | ELISA | Plasma | Stx-HUS |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25994214 | ELISA | Plasma | |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/26374997 | ELISA | Serum | Nanoparticles incubated |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/26556948 | ELISA | Amniotic Fluid | |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/26579969 | ELISA | Serum | |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27777575 | ELISA | Serum | |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28803115 | ELISA | Serum | |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2018 | https://www.ncbi.nlm.nih.gov/pubmed/29371202 | ELISA | Serum | |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 2020 | https://www.ncbi.nlm.nih.gov/pubmed/32065383 | ELISA | Plasma | Immune‐mediated thrombotic thrombocytopenic purpura |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 1995 | https://www.ncbi.nlm.nih.gov/pubmed/7554454 | ELISA | Plasma | Sickel Cell Anemia |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 1994 | https://www.ncbi.nlm.nih.gov/pubmed/7932426 | ELISA | Plasma | Rheumatoid Arthritis |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 1996 | https://www.ncbi.nlm.nih.gov/pubmed/8670328 | ELISA | Plasma | Systemic Lupus Erythematosus |
| Complement System | Bb | EIA Kit | Human | A027 | Bb Plus Fragment EIA | 1997 | https://www.ncbi.nlm.nih.gov/pubmed/9175717 | ELISA | Plasma | |
| Complement System | C3a | EIA Kit | Cynomolgus Monkey | A031 | C3a Plus EIA | 2002 | https://pubmed.ncbi.nlm.nih.gov/12469940/ | ELISA | Serum | |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2014 | https://pubmed.ncbi.nlm.nih.gov/25109258/ | ELISA | Plasma | Neuromyelitis optica |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2016 | https://pubmed.ncbi.nlm.nih.gov/27659908/ | ELISA | ARPE-19 Cells | |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2017 | https://pubmed.ncbi.nlm.nih.gov/28986975/ | ELISA | Plasma | Hereditary Angioedema |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31215772/ | ELISA | Plasma | ANCA-AAV |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31267090/ | ELISA | Aqueous humour | Age-Related Macular Degeneration |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/31672401/ | ELISA | Serum | IVIg formulations |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31730685/ | ELISA | Plasma | aHUS |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31883521/ | ELISA | CSF | Bacterial meningitis |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/32569286/ | ELISA | Plasma | FSGS |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/32569286/ | ELISA | Serum | FSGS |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/32717972/ | ELISA | Plasma | |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/32718809/ | ELISA | Serum | |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/32845615/ | ELISA | Serum | SiNP coated proteins |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/32961333/ | ELISA | Plasma | COVID-19 |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/32965482/ | ELISA | Plasma, Vitreous Humor | Proliferative Diabetic Retinopathy |
| Complement System | C3a | EIA Kit | Cynomolgus Monkey | A031 | C3a Plus EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/33069749/ | ELISA | Plasma, Serum | T-effector cell agonist (OX40) antibody |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/33123364/ | ELISA | Plasma | COVID-19 |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/33170371/ | ELISA | Serum | Lupus Nephritis, Thrombotic Microangiopathy |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/33170371/ | ELISA | Urine | Lupus Nephritis, Thrombotic Microangiopathy |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/33974276/ | ELISA | Serum | COVID-19 |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34245915/ | ELISA | Plasma | C3G |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34245915/ | ELISA | Urine | C3G |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34381048/ | ELISA | Plasma | |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34489939/ | ELISA | Peritoneal fluid (w/ Endometriosis) | |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34491250/ | ELISA | Plasma | Cancer, COVID-19 |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34491250/ | ELISA | Plasma | COVID-19 |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34732467/ | ELISA | Plasma | |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35474654/ | ELISA | Plasma | Heat-related illnesses |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35571000/ | ELISA | Urine | AAV, FSGS, IgAN, MN, and LN |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35572977/ | ELISA | Plasma | COVID-19 |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35594041/ | ELISA | Plasma | Age-Related Macular Degeneration |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35685318/ | ELISA | Serum | IgA Nephropathy |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35768780/ | ELISA | Plasma | Hemodialysis |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35785477/ | ELISA | Plasma | Obesity |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/36143371/ | ELISA | Plasma | COVID-19 |
| Complement System | C3a | EIA Kit | Human, Primate | A031 | C3a Plus EIA | 2010 | https://www.ncbi.nlm.nih.gov/pubmed/20375551 | ELISA | Serum | |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21496117 | ELISA | Plasma | |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21542928 | ELISA | Serum | |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21598302 | ELISA | Peripheral blood mononuclear cells | |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22246034 | ELISA | Serum | GEnCs and HUVEC exposed |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22583529 | ELISA | Plasma | |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23320099 | ELISA | Serum | Borrelia valaisiana incubated |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23537925 | ELISA | Ear Fluid (MEE) | |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23537925 | ELISA | Serum | |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23564505 | ELISA | Serum | |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23741476 | ELISA | CSF | |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/24260121 | ELISA | Serum | |
| Complement System | C3a | EIA Kit | Cell Culture | A031 | C3a Plus EIA | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/24613353 | ELISA | SKOV3ip1 cells | |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/24672300 | ELISA | Plasma | Lupus Nephritis |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/24854857 | ELISA | Plasma | |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/25960946 | ELISA | CSF | Listeria meningitis |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25994214 | ELISA | Plasma | |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/26091360 | ELISA | ARPE-19 Cells | |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/26091360 | ELISA | Serum | |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/26579969 | ELISA | Serum | Porcine articular chondrocytes |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27590476 | ELISA | Plasma | |
| Complement System | C3a | EIA Kit | Mouse | A031 | C3a Plus EIA | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/29018286 | ELISA | Neuron Cells | |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/29107969 | ELISA | Plasma | |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/29141676 | ELISA | Plasma | ANCA-AAV |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/29184132 | ELISA | Plasma | |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2020 | https://www.ncbi.nlm.nih.gov/pubmed/32065383 | ELISA | Plasma | Immune‐mediated thrombotic thrombocytopenic purpura |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 1995 | https://www.ncbi.nlm.nih.gov/pubmed/7554454 | ELISA | Plasma | Sickel Cell Anemia |
| Complement System | C3a | EIA Kit | Human | A031 | C3a Plus EIA | 2023 | https://pubmed.ncbi.nlm.nih.gov/37155564/ | ELISA | Supernatent | Latex beads with poE2, apoE3, or apoE4 |
| Complement System | Ba | EIA Kit | Human | A033 | Ba Fragment EIA | 2015 | https://pubmed.ncbi.nlm.nih.gov/26673143/ | ELISA | GMVEC cells, HUVEC cells | |
| Complement System | Ba | EIA Kit | Human | A033 | Ba Fragment EIA | 2018 | https://pubmed.ncbi.nlm.nih.gov/29555686/ | ELISA | GMVEC cells, BMVEC cells | |
| Complement System | Ba | EIA Kit | Human | A033 | Ba Fragment EIA | 2018 | https://pubmed.ncbi.nlm.nih.gov/29925688/ | ELISA | Serum | Microvesicles with heme |
| Complement System | Ba | EIA Kit | Human | A033 | Ba Fragment EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31267090/ | ELISA | Aqueous humour | Age-Related Macular Degeneration |
| Complement System | Ba | EIA Kit | Human | A033 | Ba Fragment EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31884386/ | ELISA | Plasma | Antibody-mediated endothelial injury |
| Complement System | Ba | EIA Kit | Human | A033 | Ba Fragment EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/32750037/ | ELISA | Bronchoalveolar lavage | Lung transplant |
| Complement System | Ba | EIA Kit | Human | A033 | Ba Fragment EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/32965482/ | ELISA | Plasma, Vitreous Humor | Proliferative Diabetic Retinopathy |
| Complement System | Ba | EIA Kit | Human | A033 | Ba Fragment EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/33170371/ | ELISA | Serum | Lupus Nephritis, Thrombotic Microangiopathy |
| Complement System | Ba | EIA Kit | Human | A033 | Ba Fragment EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/33170371/ | ELISA | Urine | Lupus Nephritis, Thrombotic Microangiopathy |
| Complement System | Ba | EIA Kit | Human | A033 | Ba Fragment EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/33193305/ | ELISA | Chondrocytes | Supernatent |
| Complement System | Ba | EIA Kit | Human | A033 | Ba Fragment EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/33193305/ | ELISA | Synoviocytes | Supernatent |
| Complement System | Ba | EIA Kit | Human | A033 | Ba Fragment EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/33615073/ | ELISA | Urine | Membranous Nephropathy |
| Complement System | Ba | EIA Kit | Human | A033 | Ba Fragment EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/33655244/ | ELISA | Plasma | COVID-19 |
| Complement System | Ba | EIA Kit | Human | A033 | Ba Fragment EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34177889/ | ELISA | Plasma | IgA Nephropathy |
| Complement System | Ba | EIA Kit | Human | A033 | Ba Fragment EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34326846/ | ELISA | Plasma | Thrombotic Microangiopathy - TA |
| Complement System | Ba | EIA Kit | Human | A033 | Ba Fragment EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34446527/ | ELISA | Plasma | COVID-19 |
| Complement System | Ba | EIA Kit | Human | A033 | Ba Fragment EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35034207/ | ELISA | Plasma | COVID-19 |
| Complement System | Ba | EIA Kit | Human | A033 | Ba Fragment EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35034207/ | ELISA | Serum | COVID-19 |
| Complement System | Ba | EIA Kit | Human | A033 | Ba Fragment EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35474654/ | ELISA | Plasma | Heat-related illnesses |
| Complement System | Ba | EIA Kit | Human | A033 | Ba Fragment EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35517827/ | ELISA | Complement Proteins | |
| Complement System | Ba | EIA Kit | Human | A033 | Ba Fragment EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35571000/ | ELISA | Urine | AAV, FSGS, IgAN, MN, and LN |
| Complement System | Ba | EIA Kit | Human | A033 | Ba Fragment EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35594041/ | ELISA | Plasma | Age-Related Macular Degeneration |
| Complement System | Ba | EIA Kit | Human | A033 | Ba Fragment EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35887995/ | ELISA | Plasma | IgA Nephropathy |
| Complement System | Ba | EIA Kit | Human | A033 | Ba Fragment EIA | 2023 | https://pubmed.ncbi.nlm.nih.gov/36732701/ | ELISA | Plasma, Serum | Glomerulonephritis |
| Complement System | Ba | EIA Kit | Human | A033 | Ba Fragment EIA | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/24260121 | ELISA | Serum | |
| Complement System | Ba | EIA Kit | Human | A033 | Ba Fragment EIA | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/25341722 | ELISA | Plasma | C3G |
| Complement System | Ba | EIA Kit | Human | A033 | Ba Fragment EIA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25802332 | ELISA | ARPE-19 Cells | |
| Complement System | Ba | EIA Kit | Human | A033 | Ba Fragment EIA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/26245903 | ELISA | Serum | |
| Complement System | Ba | EIA Kit | Human | A033 | Ba Fragment EIA | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28086806 | ELISA | Serum | ARMS2 protein |
| Complement System | C4a | EIA Kit | Cynomolgus Monkey | A035 | C4a Fragment EIA | 2002 | https://pubmed.ncbi.nlm.nih.gov/12469940/ | ELISA | Serum | |
| Complement System | C4a | EIA Kit | Human | A035 | C4a Fragment EIA | 2014 | https://pubmed.ncbi.nlm.nih.gov/25109258/ | ELISA | Plasma | Neuromyelitis optica |
| Complement System | C4a | EIA Kit | Human | A035 | C4a Fragment EIA | 2015 | https://pubmed.ncbi.nlm.nih.gov/26280503/ | ELISA | Plasma | |
| Complement System | C4a | EIA Kit | Human | A035 | C4a Fragment EIA | 2017 | https://pubmed.ncbi.nlm.nih.gov/28986975/ | ELISA | Plasma | Hereditary Angioedema |
| Complement System | C4a | EIA Kit | Human | A035 | C4a Fragment EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31194090/ | ELISA | Urine | Diabetic nephropathy |
| Complement System | C4a | EIA Kit | Human | A035 | C4a Fragment EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/31672401/ | ELISA | Serum | IVIg formulations |
| Complement System | C4a | EIA Kit | Human | A035 | C4a Fragment EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31749804/ | ELISA | Fibroblasts | Supernatent |
| Complement System | C4a | EIA Kit | Human | A035 | C4a Fragment EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31884386/ | ELISA | Plasma | Antibody-mediated endothelial injury |
| Complement System | C4a | EIA Kit | Human | A035 | C4a Fragment EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/32845615/ | ELISA | Serum | SiNP coated proteins |
| Complement System | C4a | EIA Kit | Human | A035 | C4a Fragment EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/33170371/ | ELISA | Serum | Lupus Nephritis, Thrombotic Microangiopathy |
| Complement System | C4a | EIA Kit | Human | A035 | C4a Fragment EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/33170371/ | ELISA | Urine | Lupus Nephritis, Thrombotic Microangiopathy |
| Complement System | C4a | EIA Kit | Human | A035 | C4a Fragment EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34732467/ | ELISA | Plasma | |
| Complement System | C4a | EIA Kit | Human | A035 | C4a Fragment EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35571000/ | ELISA | Urine | AAV, FSGS, IgAN, MN, and LN |
| Complement System | C4a | EIA Kit | Human | A035 | C4a Fragment EIA | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23537925 | ELISA | Ear Fluid (MEE) | |
| Complement System | C4a | EIA Kit | Human | A035 | C4a Fragment EIA | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23537925 | ELISA | Serum | |
| Complement System | C4a | EIA Kit | Human | A035 | C4a Fragment EIA | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23964276 | ELISA | Serum | |
| Complement System | C4a | EIA Kit | Human | A035 | C4a Fragment EIA | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/24854857 | ELISA | Plasma | |
| Complement System | C4a | EIA Kit | Human | A035 | C4a Fragment EIA | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27812183 | ELISA | Plasma | Imprime yeast treated |
| Complement System | C4a | EIA Kit | Human | A035 | C4a Fragment EIA | 2018 | https://www.ncbi.nlm.nih.gov/pubmed/29531170 | ELISA | Serum | Fc activation |
| Complement System | C1-INH | EIA Kit | Human | A037 | C1-lnhibitor Plus EIA | 2013 | https://pubmed.ncbi.nlm.nih.gov/24205428/ | ELISA | Serum | Bothrops pirajai venom |
| Complement System | C1-INH | EIA Kit | Human | A037 | C1-lnhibitor Plus EIA | 2018 | https://pubmed.ncbi.nlm.nih.gov/29572748/ | ELISA | Peritoneal fluid | Endometriosis |
| Complement System | C1-INH | EIA Kit | Human | A037 | C1-lnhibitor Plus EIA | 2018 | https://pubmed.ncbi.nlm.nih.gov/30083168/ | ELISA | Plasma | Hereditary Angioedema |
| Complement System | C1-INH | EIA Kit | Human | A037 | C1-lnhibitor Plus EIA | 2018 | https://pubmed.ncbi.nlm.nih.gov/30132263/ | ELISA | Plasma | Cardiometabolic disease increased risk |
| Complement System | C1-INH | EIA Kit | Canine | A037 | C1-lnhibitor Plus EIA | 2018 | https://pubmed.ncbi.nlm.nih.gov/30243377/ | ELISA | Serum | |
| Complement System | C1-INH | EIA Kit | Human | A037 | C1-lnhibitor Plus EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/33974276/ | ELISA | Serum | COVID-19 |
| Complement System | C1-INH | EIA Kit | Human | A037 | C1-lnhibitor Plus EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34491250/ | ELISA | Plasma | Cancer, COVID-19 |
| Complement System | C1-INH | EIA Kit | Human | A037 | C1-lnhibitor Plus EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34491250/ | ELISA | Plasma | COVID-19 |
| Complement System | C1-INH | EIA Kit | Human | A037 | C1-lnhibitor Plus EIA | 2008 | https://www.ncbi.nlm.nih.gov/pubmed/18460017 | ELISA | Serum | Hereditary Angioedema |
| Complement System | C1-INH | EIA Kit | Human | A037 | C1-lnhibitor Plus EIA | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22583529 | ELISA | Serum | |
| Complement System | C1-INH | EIA Kit | Human | A037 | C1-lnhibitor Plus EIA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/26154504 | ELISA | Serum | Hereditary Angioedema |
| Complement System | C1-INH | EIA Kit | Human | A037 | C1-lnhibitor Plus EIA | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/26654922 | ELISA | Plasma | |
| Complement System | C1-INH | EIA Kit | Human | A037 | C1-lnhibitor Plus EIA | 2018 | https://www.ncbi.nlm.nih.gov/pubmed/30116749 | ELISA | Serum | B. lanceolatus venom |
| Complement System | Factor H | EIA Kit | Human | A039 | Factor H EIA | 2019 | https://pubmed.ncbi.nlm.nih.gov/31883521/ | ELISA | CSF | Bacterial meningitis |
| Complement System | Factor H | EIA Kit | Human | A039 | Factor H EIA | 2020 | https://pubmed.ncbi.nlm.nih.gov/32376801/ | ELISA | Plasma | C3G |
| Complement System | Factor H | EIA Kit | Human | A039 | Factor H EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34404360/ | ELISA | Serum | Diabetes, gestational |
| Complement System | Factor H | EIA Kit | Human | A039 | Factor H EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34491250/ | ELISA | Plasma | Cancer, COVID-19 |
| Complement System | Factor H | EIA Kit | Human | A039 | Factor H EIA | 2021 | https://pubmed.ncbi.nlm.nih.gov/34491250/ | ELISA | Plasma | COVID-19 |
| Complement System | Factor H | EIA Kit | Human | A039 | Factor H EIA | 2022 | https://pubmed.ncbi.nlm.nih.gov/35474654/ | ELISA | Plasma | Heat-related illnesses |
| Complement System | Complement Standard | Reagent | Cell Culture | A100 | Human Complement Standard | 2017 | https://pubmed.ncbi.nlm.nih.gov/28634480/ | CDC Assay | Raji cells | |
| Complement System | Complement Source | Reagent | Human | A111 | Normal Human Serum Complement | 2006 | https://www.ncbi.nlm.nih.gov/pubmed/16537476 | CDC Assay | WIL2-S cells | Rituximab |
| Complement System | Complement Source | Reagent | Cell Culture | A111 | Normal Human Serum Complement | 2008 | https://www.ncbi.nlm.nih.gov/pubmed/18025153 | CDC Assay | Daudi Cells | |
| Complement System | Complement Source | Reagent | Cell Culture | A111 | Normal Human Serum Complement | 2008 | https://www.ncbi.nlm.nih.gov/pubmed/18025153 | CDC Assay | Ramos Cells | |
| Complement System | Complement Source | Reagent | Human | A111 | Normal Human Serum Complement | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21258049 | CDC Assay | B-Cells | |
| Complement System | Complement Source | Reagent | Human | A111 | Normal Human Serum Complement | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21305012 | CDC Assay | Peripheral blood mononuclear cells | |
| Complement System | Complement Source | Reagent | Cell Culture | A111 | Normal Human Serum Complement | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21343375 | CDC Assay | sLea antigen | positive and negative cell lines |
| Complement System | Complement Source | Reagent | Human | A111 | Normal Human Serum Complement | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22531441 | CDC Assay | WIL2-S cells | CD-20 AbX antibody |
| Complement System | Complement Source | Reagent | Human | A111 | Normal Human Serum Complement | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22761788 | CDC Assay | Peripheral blood mononuclear cells | |
| Complement System | Complement Source | Reagent | Cell Culture | A111 | Normal Human Serum Complement | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23634281 | CDC Assay | RC-K8 cells | |
| Complement System | Complement Source | Reagent | Cell Culture | A111 | Normal Human Serum Complement | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23634281 | CDC Assay | SU-DHL-4 cells | |
| Complement System | Complement Source | Reagent | Cell Culture | A111 | Normal Human Serum Complement | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23658447 | CDC Assay | Huh7.5 Cells | |
| Complement System | Complement Source | Reagent | Cell Culture | A111 | Normal Human Serum Complement | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23667612 | CDC Assay | OPM-2 cells | |
| Complement System | Complement Source | Reagent | Cell Culture | A111 | Normal Human Serum Complement | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23758976 | CDC Assay | MDA-MB-231 Cells | |
| Complement System | Complement Source | Reagent | Cell Culture | A111 | Normal Human Serum Complement | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23826123 | CDC Assay | Jeko-1 Cells | Lymphoma cells |
| Complement System | Complement Source | Reagent | Cell Culture | A111 | Normal Human Serum Complement | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/24841238 | CDC Assay | Daudi Cells | |
| Complement System | Complement Source | Reagent | Cell Culture | A111 | Normal Human Serum Complement | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/24963443 | CDC Assay | WIL2-S cells | |
| Complement System | Complement Source | Reagent | Cell Culture | A111 | Normal Human Serum Complement | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/26196962 | CDC Assay | CHO Cells | |
| Complement System | Complement Source | Reagent | Cell Culture | A111 | Normal Human Serum Complement | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27367933 | CDC Assay | KIT225/K6 cells | |
| Complement System | Complement Source | Reagent | Human | A111 | Normal Human Serum Complement | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28102191 | CDC Assay | A549 cells | |
| Complement System | Complement Source | Reagent | Human | A111 | Normal Human Serum Complement | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28102191 | CDC Assay | WIL2-S cells | |
| Complement System | Complement Source | Reagent | Cell Culture | A111 | Normal Human Serum Complement | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28542350 | CDC Assay | CHO cells | |
| Complement System | Complement Source | Reagent | Human | A111 | Normal Human Serum Complement | 2021 | https://pubmed.ncbi.nlm.nih.gov/34169354/ | Complement Activation Assay | Disc Tissue | |
| Complement System | Complement Source | Reagent | Human | A111 | Normal Human Serum Complement | 2021 | https://pubmed.ncbi.nlm.nih.gov/34296421/ | ELISA | Serum | |
| Complement System | Complement Source | Reagent | Bacteria | A111 | Normal Human Serum Complement | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/25101794 | ELISA | Salmonella enterica | |
| Complement System | Complement Source | Reagent | Human | A111 | Normal Human Serum Complement | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/25205869 | ELISA | Serum | |
| Complement System | Complement Source | Reagent | Virus | A111 | Normal Human Serum Complement | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/26121641 | ELISA | HIV | Purified |
| Complement System | Complement Source | Reagent | Bacteria | A111 | Normal Human Serum Complement | 2018 | https://pubmed.ncbi.nlm.nih.gov/29535198/ | FC | Streptococcus pneumoniae | |
| Complement System | Complement Source | Reagent | Human | A111 | Normal Human Serum Complement | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23459111 | FC | Serum | Staphylococcus epidermidis incubated |
| Complement System | Complement Source | Reagent | Bacteria | A111 | Normal Human Serum Complement | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23860765 | FC | Salmonella enterica | |
| Complement System | Complement Source | Reagent | Human | A111 | Normal Human Serum Complement | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28790822 | FC | Peripheral blood mononuclear cells | |
| Complement System | Complement Source | Reagent | Human | A111 | Normal Human Serum Complement | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23282236 | Mass Spec | Red Blood Cells | |
| Complement System | Complement Source | Reagent | Cell Culture | A111 | Normal Human Serum Complement | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27399785 | Phagocytosis assay | THP-1 Cells | |
| Complement System | Complement Source | Reagent | Human | A111 | Normal Human Serum Complement | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/19386604 | TER Measurements | ARPE-19 Cells | |
| Complement System | Complement Source | Reagent | Cell Culture | A111 | Normal Human Serum Complement | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22408008 | TER Measurements | RPE Cells | |
| Complement System | Complement Source | Reagent | Virus | A111 | Normal Human Serum Complement | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/23063584 | VCA | HIV | Purified |
| Complement System | Complement Source | Reagent | Human | A121 | Guinea Pig Serum Complement | 2008 | https://pubmed.ncbi.nlm.nih.gov/19005576/ | Complement Activation Assay | Serum | Floridoside incubated |
| Complement System | C1q | Antibody | Human | A201 | C1q Antibody (monoclonal) | 2021 | https://pubmed.ncbi.nlm.nih.gov/34160562/ | ELISA | Eye Tissue | Age-Related Macular Degeneration |
| Complement System | C1q | Antibody | Bacteria | A201 | C1q Antibody (monoclonal) | 2021 | https://pubmed.ncbi.nlm.nih.gov/34778603/ | ELISA | Mycobacterium tuberculosis | |
| Complement System | C1q | Antibody | Human | A201 | C1q Antibody (monoclonal) | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/19925495 | ELISA | Plasma | |
| Complement System | C1q | Antibody | Human | A201 | C1q Antibody (monoclonal) | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21397947 | ELISA | Dendritic Cell | |
| Complement System | C1q | Antibody | Human | A201 | C1q Antibody (monoclonal) | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/26196285 | ELISA | C1 protein | |
| Complement System | C1q | Antibody | Human | A201 | C1q Antibody (monoclonal) | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/29209316 | ELISA | Mesenchymal Cells | |
| Complement System | C1q | Antibody | Human | A201 | C1q Antibody (monoclonal) | 2018 | https://www.ncbi.nlm.nih.gov/pubmed/30134810 | ELISA | Serum | Systemic Lupus Erythematosus |
| Complement System | C1q | Antibody | Human | A201 | C1q Antibody (monoclonal) | 2008 | https://www.ncbi.nlm.nih.gov/pubmed/18295334 | ELISA, FC | Endothelial Cells | DEC, UtMEC, ADMEC, HUVEC |
| Complement System | C1q | Antibody | Cell Culture | A201 | C1q Antibody (monoclonal) | 2017 | https://pubmed.ncbi.nlm.nih.gov/28634480/ | FC | Raji cells | |
| Complement System | C1q | Antibody | Cell Culture | A201 | C1q Antibody (monoclonal) | 2020 | https://pubmed.ncbi.nlm.nih.gov/32296440/ | FC | THP-1 Cells | |
| Complement System | C1q | Antibody | Human | A201 | C1q Antibody (monoclonal) | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/19864605 | FC | Jurkat Cells | |
| Complement System | C1q | Antibody | Human | A201 | C1q Antibody (monoclonal) | 2010 | https://www.ncbi.nlm.nih.gov/pubmed/19919576 | FC | Neuron Cells | Apoptosis |
| Complement System | C1q | Antibody | Human | A201 | C1q Antibody (monoclonal) | 2010 | https://www.ncbi.nlm.nih.gov/pubmed/19919576 | FC | Neuron Cells | |
| Complement System | C1q | Antibody | Cell Culture | A201 | C1q Antibody (monoclonal) | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23667612 | FC | OPM-2 cells | |
| Complement System | C1q | Antibody | Human | A201 | C1q Antibody (monoclonal) | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27812183 | FC | Neutrophils | Imprime yeast treated |
| Complement System | C1q | Antibody | Human | A201 | C1q Antibody (monoclonal) | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27812183 | FC | Monocytes | |
| Complement System | C1q | Antibody | Rat | A201 | C1q Antibody (monoclonal) | 2018 | https://www.ncbi.nlm.nih.gov/pubmed/29755460 | FC, IF | Basophilic Leukemia cells | |
| Complement System | C1q | Antibody | Human | A201 | C1q Antibody (monoclonal) | 2018 | https://www.ncbi.nlm.nih.gov/pubmed/29755460 | FC, IF | Red Blood Cells | |
| Complement System | C1q | Antibody | Human | A201 | C1q Antibody (monoclonal) | 2010 | https://www.ncbi.nlm.nih.gov/pubmed/20456695 | FC, WB | Hematopoietic stem/progenitor cells | |
| Complement System | C1q | Antibody | Human | A201 | C1q Antibody (monoclonal) | 2021 | https://pubmed.ncbi.nlm.nih.gov/34252574/ | IF | Kidney Tissue | COVID-19 |
| Complement System | C1q | Antibody | Mouse | A201 | C1q Antibody (monoclonal) | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27008854 | IF | Retina Tissue | |
| Complement System | C1q | Antibody | Rhesus Monkey | A201 | C1q Antibody (monoclonal) | 2005 | https://www.ncbi.nlm.nih.gov/pubmed/15992964 | IHC | Brain Tissue | |
| Complement System | C1q | Antibody | Human | A201 | C1q Antibody (monoclonal) | 2016 | https://pubmed.ncbi.nlm.nih.gov/27659908/ | WB | ARPE-19 Cells | |
| Complement System | C1q | Antibody | Human | A203 | C1q Antibody (monoclonal) | 1998 | https://pubmed.ncbi.nlm.nih.gov/9712784/ | Complement Activation Assay | Polymorphonuclear Cells | Cryptococcus neoformans |
| Complement System | C1q | Antibody | Human | A203 | C1q Antibody (monoclonal) | 2006 | https://www.ncbi.nlm.nih.gov/pubmed/17172439 | Electron Microscopy | Purified protein | |
| Complement System | C1q | Antibody | Human | A203 | C1q Antibody (monoclonal) | 2013 | https://pubmed.ncbi.nlm.nih.gov/23692858/ | FC | HUVEC Cells | aHUS |
| Complement System | C3c | Antibody | Human | A205 | C3 (C3c) Antibody (monoclonal) | 2018 | https://pubmed.ncbi.nlm.nih.gov/30309891/ | ELISA | Plasma | Platelet factor 4 (PF4)/heparin complexes |
| Complement System | C3c | Antibody | Human | A205 | C3 (C3c) Antibody (monoclonal) | 2021 | https://pubmed.ncbi.nlm.nih.gov/34160562/ | ELISA | Eye Tissue | Age-Related Macular Degeneration |
| Complement System | C3c | Antibody | Human | A205 | C3 (C3c) Antibody (monoclonal) | 2013 | https://pubmed.ncbi.nlm.nih.gov/23692858/ | FC | HUVEC Cells | aHUS |
| Complement System | C3c | Antibody | Human | A205 | C3 (C3c) Antibody (monoclonal) | 2018 | https://pubmed.ncbi.nlm.nih.gov/29925688/ | FC | HUVEC Cells | Microvesicles with heme |
| Complement System | C3c | Antibody | Cell Culture | A205 | C3 (C3c) Antibody (monoclonal) | 2018 | https://pubmed.ncbi.nlm.nih.gov/30619356/ | FC | Endothelial Cells | HUVEC Cells, HMEC Cells, HRGEC Cells |
| Complement System | C3c | Antibody | Cell Culture | A205 | C3 (C3c) Antibody (monoclonal) | 2020 | https://pubmed.ncbi.nlm.nih.gov/32793201/ | FC | HUVEC Cells | |
| Complement System | C3c | Antibody | Hamster | A205 | C3 (C3c) Antibody (monoclonal) | 2002 | https://www.ncbi.nlm.nih.gov/pubmed/12055245 | FC | CHO Cells | MCP Transfected |
| Complement System | C3c | Antibody | Cell Culture | A205 | C3 (C3c) Antibody (monoclonal) | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22246034 | FC | GEnCs cells | |
| Complement System | C3c | Antibody | Cell Culture | A205 | C3 (C3c) Antibody (monoclonal) | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22246034 | FC | HUVEC Cells | |
| Complement System | C3c | Antibody | Cell Culture | A205 | C3 (C3c) Antibody (monoclonal) | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/24652797 | FC | HUVEC Cells | |
| Complement System | C3c | Antibody | Cell Culture | A205 | C3 (C3c) Antibody (monoclonal) | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25608561 | FC | HUVEC Cells | |
| Complement System | C3c | Antibody | Human | A205 | C3 (C3c) Antibody (monoclonal) | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/26245903 | FC | Endothelial Cells | |
| Complement System | C3c | Antibody | Cell Culture | A205 | C3 (C3c) Antibody (monoclonal) | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/26260209 | FC | CHO Cells | |
| Complement System | C3c | Antibody | Cell Culture | A205 | C3 (C3c) Antibody (monoclonal) | 2019 | https://www.ncbi.nlm.nih.gov/pubmed/31078967 | FC | HUVEC Cells | |
| Complement System | C3c | Antibody | Cell Culture | A205 | C3 (C3c) Antibody (monoclonal) | 2021 | https://pubmed.ncbi.nlm.nih.gov/35052426/ | IF | MDA-MB-231 Cells | |
| Complement System | C3c | Antibody | Bacteria | A205 | C3 (C3c) Antibody (monoclonal) | 2022 | https://pubmed.ncbi.nlm.nih.gov/35303742/ | WB | Borrelia hermsii | |
| Complement System | C3d | Antibody | Human | A207 | C3 (C3d) Antibody (monoclonal) | 2017 | https://pubmed.ncbi.nlm.nih.gov/28640379/ | ELISA | Serum | Diabetes |
| Complement System | C3d | Antibody | Human | A207 | C3 (C3d) Antibody (monoclonal) | 2003 | https://www.ncbi.nlm.nih.gov/pubmed/14517274 | FC | Serum | S. pyrogenes incubated |
| Complement System | C3d | Antibody | Cell Culture | A207 | C3 (C3d) Antibody (monoclonal) | 1992 | https://www.ncbi.nlm.nih.gov/pubmed/1588280 | FC | NIH/3T3 Cells | MCP Transfected |
| Complement System | C3d | Antibody | Human | A207 | C3 (C3d) Antibody (monoclonal) | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/20727163 | FC | Serum | S. pneumoniae incubated |
| Complement System | C3d | Antibody | Cell Culture | A207 | C3 (C3d) Antibody (monoclonal) | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/26260209 | FC | CHO Cells | |
| Complement System | C3d | Antibody | Human | A207 | C3 (C3d) Antibody (monoclonal) | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/26784696 | FC | Red Blood Cells | |
| Complement System | C3d | Antibody | Human | A207 | C3 (C3d) Antibody (monoclonal) | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27918307 | IF | iPS cells | ARMD CFH 402 polymorphism |
| Complement System | C3d | Antibody | Human | A207 | C3 (C3d) Antibody (monoclonal) | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28362874 | IHC | Aorta Tissue | |
| Complement System | C3d | Antibody | Human | A207 | C3 (C3d) Antibody (monoclonal) | 2015 | https://pubmed.ncbi.nlm.nih.gov/26248865/ | WB | Serum | Acetyl salicylic acid dimer 5,5'-methylenebis(2-acetoxybenzoic acid) (DAS) |
| Complement System | iC3b | Antibody | Cell Culture | A209 | iC3b Antibody (monoclonal - neoantigen) | 2002 | https://www.ncbi.nlm.nih.gov/pubmed/12486098 | Confocal Microscopy | Jurkat Cells | |
| Complement System | iC3b | Antibody | Human | A209 | iC3b Antibody (monoclonal - neoantigen) | 2021 | https://pubmed.ncbi.nlm.nih.gov/35935964/ | ELISA | Plasma | Sickel Cell Anemia |
| Complement System | iC3b | Antibody | Human | A209 | iC3b Antibody (monoclonal - neoantigen) | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/19925495 | ELISA | Plasma | |
| Complement System | iC3b | Antibody | Human | A209 | iC3b Antibody (monoclonal - neoantigen) | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28375048 | ELISA | Serum | |
| Complement System | iC3b | Antibody | Human | A209 | iC3b Antibody (monoclonal - neoantigen) | 2018 | https://www.ncbi.nlm.nih.gov/pubmed/29632531 | ELISA | Serum | |
| Complement System | iC3b | Antibody | Human | A209 | iC3b Antibody (monoclonal - neoantigen) | 2018 | https://www.ncbi.nlm.nih.gov/pubmed/29782502 | ELISA | Plasma | Age-Related Macular Degeneration |
| Complement System | iC3b | Antibody | Human | A209 | iC3b Antibody (monoclonal - neoantigen) | 2018 | https://www.ncbi.nlm.nih.gov/pubmed/29782502 | ELISA | Plasma | Alzheimer's Disease |
| Complement System | iC3b | Antibody | Human | A209 | iC3b Antibody (monoclonal - neoantigen) | 1998 | https://www.ncbi.nlm.nih.gov/pubmed/9687521 | ELISA | Amyloid-βeta peptides & NHS | |
| Complement System | iC3b | Antibody | Human | A209 | iC3b Antibody (monoclonal - neoantigen) | 2013 | https://pubmed.ncbi.nlm.nih.gov/23692858/ | FC | HUVEC Cells | aHUS |
| Complement System | iC3b | Antibody | Parasite | A209 | iC3b Antibody (monoclonal - neoantigen) | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22451519 | FC | Entamoeba histolytica | |
| Complement System | iC3b | Antibody | Human | A209 | iC3b Antibody (monoclonal - neoantigen) | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27304426 | FC | Serum | B. anthracis incubated |
| Complement System | iC3b | Antibody | Human | A209 | iC3b Antibody (monoclonal - neoantigen) | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28629435 | FC | Red Blood Cells | PNH |
| Complement System | iC3b | Antibody | Human | A209 | iC3b Antibody (monoclonal - neoantigen) | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/29209332 | FC | NK Cells | |
| Complement System | iC3b | Antibody | Human | A209 | iC3b Antibody (monoclonal - neoantigen) | 2006 | https://www.ncbi.nlm.nih.gov/pubmed/17052351 | ICC, IHC | Brain Tissue | |
| Complement System | iC3b | Antibody | Human | A209 | iC3b Antibody (monoclonal - neoantigen) | 2008 | https://www.ncbi.nlm.nih.gov/pubmed/18334032 | ICC, IHC | Brain Tissue | |
| Complement System | iC3b | Antibody | Human | A209 | iC3b Antibody (monoclonal - neoantigen) | 2022 | https://pubmed.ncbi.nlm.nih.gov/35747245/ | IHC | Skin Tissue | Cutaneous Vasculitis |
| Complement System | iC3b | Antibody | Human | A209 | iC3b Antibody (monoclonal - neoantigen) | 2000 | https://www.ncbi.nlm.nih.gov/pubmed/10980130 | IHC | Brain Tissue | Fetal |
| Complement System | iC3b | Antibody | Human | A209 | iC3b Antibody (monoclonal - neoantigen) | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21860027 | IHC | Lung Tissue | Asthmatic Alzheimer's |
| Complement System | iC3b | Antibody | Human | A209 | iC3b Antibody (monoclonal - neoantigen) | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21860027 | IHC | Lung Tissue | |
| Complement System | iC3b | Antibody | Human | A209 | iC3b Antibody (monoclonal - neoantigen) | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25603857 | IHC | Brain Tissue | Medullablastoma |
| Complement System | iC3b | Antibody | Human | A209 | iC3b Antibody (monoclonal - neoantigen) | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25660530 | Lateral Flow Assay | Plasma | |
| Complement System | iC3b | Antibody | Bacteria | A209 | iC3b Antibody (monoclonal - neoantigen) | 2007 | https://pubmed.ncbi.nlm.nih.gov/17220305/ | WB | Pneumococci | |
| Complement System | iC3b | Antibody | Human | A209 | iC3b Antibody (monoclonal - neoantigen) | 2021 | https://pubmed.ncbi.nlm.nih.gov/34338598/ | WB | Serum | Aspergillus incubated |
| Complement System | C4c | Antibody | Human | A211 | C4 (C4c) Antibody (monoclonal) | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21397947 | ELISA | Dendritic Cell | |
| Complement System | C4c | Antibody | Human | A211 | C4 (C4c) Antibody (monoclonal) | 2023 | https://pubmed.ncbi.nlm.nih.gov/37118504/ | ELISA | CSF | Alzheimer's Disease |
| Complement System | C4c | Antibody | Human | A211 | C4 (C4c) Antibody (monoclonal) | 2013 | https://pubmed.ncbi.nlm.nih.gov/24064215/ | FC | Serum | S. pyogenes incubated |
| Complement System | C4c | Antibody | Human | A211 | C4 (C4c) Antibody (monoclonal) | 2001 | https://www.ncbi.nlm.nih.gov/pubmed/11157049 | FC | Serum | Neisseria gonorrhoeae |
| Complement System | C4c | Antibody | Hamster | A211 | C4 (C4c) Antibody (monoclonal) | 2002 | https://www.ncbi.nlm.nih.gov/pubmed/12055245 | FC | CHO Cells | MCP Transfected |
| Complement System | C4c | Antibody | Human | A211 | C4 (C4c) Antibody (monoclonal) | 2003 | https://www.ncbi.nlm.nih.gov/pubmed/14517274 | FC | Serum | S. pyrogenes incubated |
| Complement System | C4c | Antibody | Human | A211 | C4 (C4c) Antibody (monoclonal) | 2006 | https://www.ncbi.nlm.nih.gov/pubmed/16495531 | FC | Serum | Moraxella catarrhalis |
| Complement System | C4c | Antibody | Human | A211 | C4 (C4c) Antibody (monoclonal) | 2006 | https://www.ncbi.nlm.nih.gov/pubmed/16495531 | FC | Serum | Neisseria gonorrhoeae |
| Complement System | C4c | Antibody | Human | A211 | C4 (C4c) Antibody (monoclonal) | 2007 | https://www.ncbi.nlm.nih.gov/pubmed/17526744 | FC | Serum | Neisseria gonorrhoeae |
| Complement System | C4c | Antibody | Hamster | A211 | C4 (C4c) Antibody (monoclonal) | 2008 | https://www.ncbi.nlm.nih.gov/pubmed/17914026 | FC | CHO Cells | MCP Transfected |
| Complement System | C4c | Antibody | Human | A211 | C4 (C4c) Antibody (monoclonal) | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21280005 | FC | Serum | Systemic Lupus Erythematosus |
| Complement System | C4c | Antibody | Cell Culture | A211 | C4 (C4c) Antibody (monoclonal) | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21915248 | FC | Jurkat Cells | |
| Complement System | C4c | Antibody | Cell Culture | A211 | C4 (C4c) Antibody (monoclonal) | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/26260209 | FC | CHO Cells | |
| Complement System | C4c | Antibody | Human | A211 | C4 (C4c) Antibody (monoclonal) | 2008 | https://www.ncbi.nlm.nih.gov/pubmed/18295334 | IHC | Endothelium Tissue | |
| Complement System | C4d | Antibody | Human | A213 | C4 (C4d) Antibody (monoclonal) | 2003 | https://www.ncbi.nlm.nih.gov/pubmed/14517274 | FC | Serum | S. pyrogenes incubated |
| Complement System | C4d | Antibody | Human | A213 | C4 (C4d) Antibody (monoclonal) | 2006 | https://www.ncbi.nlm.nih.gov/pubmed/16495531 | FC | Serum | Moraxella catarrhalis |
| Complement System | C4d | Antibody | Human | A213 | C4 (C4d) Antibody (monoclonal) | 2006 | https://www.ncbi.nlm.nih.gov/pubmed/16495531 | FC | Serum | Neisseria gonorrhoeae |
| Complement System | C4d | Antibody | Human | A213 | C4 (C4d) Antibody (monoclonal) | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/24448198 | FC | Red Blood Cells | Trauma |
| Complement System | C4d | Antibody | Cell Culture | A213 | C4 (C4d) Antibody (monoclonal) | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/26260209 | FC | CHO Cells | |
| Complement System | C4d | Antibody | Human | A213 | C4 (C4d) Antibody (monoclonal) | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/26784696 | FC | Red Blood Cells | |
| Complement System | C4d | Antibody | Human | A213 | C4 (C4d) Antibody (monoclonal) | 2013 | https://pubmed.ncbi.nlm.nih.gov/24064215/ | FC, WB | Serum | S. pyogenes incubated |
| Complement System | C4d | Antibody | Human | A213 | C4 (C4d) Antibody (monoclonal) | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27918307 | IF | iPS cells | |
| Complement System | C4d | Antibody | Human | A213 | C4 (C4d) Antibody (monoclonal) | 2020 | https://pubmed.ncbi.nlm.nih.gov/33058948/ | IHC | Skin Tissue | COVID-19 |
| Complement System | C4d | Antibody | Human | A213 | C4 (C4d) Antibody (monoclonal) | 2015 | https://pubmed.ncbi.nlm.nih.gov/26248865/ | WB | Serum | Acetyl salicylic acid dimer 5,5'-methylenebis(2-acetoxybenzoic acid) (DAS) |
| Complement System | C4BP | Antibody | Human | A215 | C4BP Antibody (monoclonal) | 2001 | https://www.ncbi.nlm.nih.gov/pubmed/11157049 | FC | Serum | Neisseria gonorrhoeae |
| Complement System | C4BP | Antibody | Human | A215 | C4BP Antibody (monoclonal) | 2006 | https://www.ncbi.nlm.nih.gov/pubmed/16495531 | FC | Serum | Moraxella catarrhalis |
| Complement System | C4BP | Antibody | Human | A215 | C4BP Antibody (monoclonal) | 2006 | https://www.ncbi.nlm.nih.gov/pubmed/16495531 | FC | Serum | Neisseria gonorrhoeae |
| Complement System | C4BP | Antibody | Bacteria | A215 | C4BP Antibody (monoclonal) | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/22102907 | FC | Salmonella enterica | |
| Complement System | C4BP | Antibody | Human | A215 | C4BP Antibody (monoclonal) | 2019 | https://pubmed.ncbi.nlm.nih.gov/31620138/ | IF | Embryo Tissue | |
| Complement System | C4BP | Antibody | Human | A215 | C4BP Antibody (monoclonal) | 2010 | https://pubmed.ncbi.nlm.nih.gov/20439477/ | WB | Serum | Neisseria gonorrhoeae |
| Complement System | C4BP | Antibody | Human | A215 | C4BP Antibody (monoclonal) | 2005 | https://www.ncbi.nlm.nih.gov/pubmed/15908371 | WB | Serum | Haemophilus ducreyi incubated |
| Complement System | C4BP | Antibody | Bacteria | A215 | C4BP Antibody (monoclonal) | 2010 | https://www.ncbi.nlm.nih.gov/pubmed/20532227 | WB | Cell Lysate | Borrelia recurrentis |
| Complement System | C5 | Antibody | Human | A217 | C5 Antibody (monoclonal) | 2014 | https://pubmed.ncbi.nlm.nih.gov/24797388/ | Complement Activation Assay | Serum | |
| Complement System | C5 | Antibody | Human | A217 | C5 Antibody (monoclonal) | 2019 | https://pubmed.ncbi.nlm.nih.gov/30635392/ | Complement Activation Assay | B-Cells | |
| Complement System | C5 | Antibody | Human | A217 | C5 Antibody (monoclonal) | 2019 | https://pubmed.ncbi.nlm.nih.gov/31263464/ | ELISA | Plasma | |
| Complement System | C5 | Antibody | Human | A217 | C5 Antibody (monoclonal) | 2019 | https://pubmed.ncbi.nlm.nih.gov/31263464/ | ELISA | Serum | |
| Complement System | C5 | Antibody | Human | A217 | C5 Antibody (monoclonal) | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21860027 | ELISA | Serum | |
| Complement System | C5 | Antibody | Cell Culture | A217 | C5 Antibody (monoclonal) | 2015 | https://pubmed.ncbi.nlm.nih.gov/25904443/ | FC | HAEC Cells | |
| Complement System | C5 | Antibody | Hamster | A217 | C5 Antibody (monoclonal) | 2002 | https://www.ncbi.nlm.nih.gov/pubmed/12055245 | FC | CHO Cells | MCP Transfected |
| Complement System | C5 | Antibody | Human | A217 | C5 Antibody (monoclonal) | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25887232 | IHC | Kidney Tissue | |
| Complement System | C5 | Antibody | Human | A217 | C5 Antibody (monoclonal) | 2019 | https://pubmed.ncbi.nlm.nih.gov/30601845/ | WB | Plasma | Chronic Lymphocytic Leukemia |
| Complement System | C6 | Antibody | Human | A219 | C6 Antibody (monoclonal) | 2018 | https://pubmed.ncbi.nlm.nih.gov/30555486/ | ELISA | Serum | |
| Complement System | C6 | Antibody | Bacteria | A219 | C6 Antibody (monoclonal) | 2020 | https://pubmed.ncbi.nlm.nih.gov/32569291/ | ELISA | E. Coli | Supernatent |
| Complement System | C6 | Antibody | Human | A219 | C6 Antibody (monoclonal) | 2022 | https://pubmed.ncbi.nlm.nih.gov/35947526/ | ELISA | Serum | Escherichia coli |
| Complement System | C6 | Antibody | Human | A219 | C6 Antibody (monoclonal) | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27716448 | ELISA | Synovial fluid | |
| Complement System | C7 | Antibody | Rat | A221 | C7 Antibody (monoclonal) | 2008 | https://pubmed.ncbi.nlm.nih.gov/18578885/ | FC, IF | Spinal Cord Tissue | |
| Complement System | C7 | Antibody | Bacteria | A221 | C7 Antibody (monoclonal) | 2015 | https://pubmed.ncbi.nlm.nih.gov/25739917/ | Opsonophagocytic killing assay | Neisseria meningitidis | |
| Complement System | C7 | Antibody | Human | A221 | C7 Antibody (monoclonal) | 2014 | https://pubmed.ncbi.nlm.nih.gov/24554772/ | Phagocytosis assay | Whole Blood | |
| Complement System | C7 | Antibody | Human | A221 | C7 Antibody (monoclonal) | 2017 | https://pubmed.ncbi.nlm.nih.gov/28630122/ | Serum Bactericidal Assay | Serum | Neisseria meningitidis |
| Complement System | C9 | Antibody | Human | A223 | C9 Antibody (monoclonal) | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25887232 | IHC | Kidney Tissue | |
| Complement System | Ba | Antibody | Human | A225 | Factor B (Ba) Antibody (monoclonal) | 2014 | https://pubmed.ncbi.nlm.nih.gov/24797388/ | Complement Activation Assay | Serum | |
| Complement System | Ba | Antibody | Human | A225 | Factor B (Ba) Antibody (monoclonal) | 2015 | https://pubmed.ncbi.nlm.nih.gov/26673143/ | ELISA | GMVEC cells, HUVEC cells | |
| Complement System | Ba | Antibody | Human | A225 | Factor B (Ba) Antibody (monoclonal) | 2018 | https://pubmed.ncbi.nlm.nih.gov/29555686/ | ELISA | GMVEC cells, BMVEC cells | |
| Complement System | Ba | Antibody | Human | A225 | Factor B (Ba) Antibody (monoclonal) | 2021 | https://pubmed.ncbi.nlm.nih.gov/34177949/ | ELISA | Serum | |
| Complement System | Bb | Antibody | Human | A227 | Factor B (Bb) Antibody (monoclonal) | 2020 | https://pubmed.ncbi.nlm.nih.gov/31924231/ | ELISA | Serum | |
| Complement System | Bb | Antibody | Human | A227 | Factor B (Bb) Antibody (monoclonal) | 2007 | https://www.ncbi.nlm.nih.gov/pubmed/17526744 | ELISA | Serum | Neisseria gonorrhoeae |
| Complement System | Bb | Antibody | Human | A227 | Factor B (Bb) Antibody (monoclonal) | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27146825 | ELISA | Serum | |
| Complement System | Bb | Antibody | Human | A227 | Factor B (Bb) Antibody (monoclonal) | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22064712 | FC | Serum | Meningococcal infected |
| Complement System | Bb | Antibody | Human | A227 | Factor B (Bb) Antibody (monoclonal) | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/26106082 | FC | Serum | Meningococcal infected |
| Complement System | Bb | Antibody | Human | A227 | Factor B (Bb) Antibody (monoclonal) | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28629435 | FC | Red Blood Cells | PNH |
| Complement System | Factor H | Antibody | Human | A229 | Factor H Antibody (monoclonal) | 2019 | https://pubmed.ncbi.nlm.nih.gov/31263464/ | ELISA | Plasma | |
| Complement System | Factor H | Antibody | Human | A229 | Factor H Antibody (monoclonal) | 2019 | https://pubmed.ncbi.nlm.nih.gov/31263464/ | ELISA | Serum | |
| Complement System | Factor H | Antibody | Human | A229 | Factor H Antibody (monoclonal) | 2021 | https://pubmed.ncbi.nlm.nih.gov/34912830/ | ELISA | Protein | Factor H WT and Variants |
| Complement System | Factor H | Antibody | Cell Culture | A229 | Factor H Antibody (monoclonal) | 2018 | https://pubmed.ncbi.nlm.nih.gov/30619356/ | FC | Endothelial Cells | HUVEC Cells, HMEC Cells, HRGEC Cells |
| Complement System | Factor H | Antibody | Human | A229 | Factor H Antibody (monoclonal) | 2021 | https://pubmed.ncbi.nlm.nih.gov/34252574/ | IF | Kidney Tissue | COVID-19 |
| Complement System | Factor H | Antibody | Bacteria | A229 | Factor H Antibody (monoclonal) | 2006 | https://www.ncbi.nlm.nih.gov/pubmed/16622202 | IF, WB | Leptospira interrogans | |
| Complement System | Factor H | Antibody | N/A | A229 | Factor H Antibody (monoclonal) | 2018 | https://pubmed.ncbi.nlm.nih.gov/29535198/ | WB | Protein | PspC |
| Complement System | Factor P | Antibody | Human | A233 | Factor P Antibody (monoclonal) #1 | 2014 | https://pubmed.ncbi.nlm.nih.gov/24797388/ | ELISA | Plasma | |
| Complement System | Factor P | Antibody | Human | A233 | Factor P Antibody (monoclonal) #1 | 2019 | https://pubmed.ncbi.nlm.nih.gov/31263464/ | ELISA | Plasma | |
| Complement System | Factor P | Antibody | Human | A233 | Factor P Antibody (monoclonal) #1 | 2019 | https://pubmed.ncbi.nlm.nih.gov/31263464/ | ELISA | Serum | |
| Complement System | Factor P | Antibody | Human | A233 | Factor P Antibody (monoclonal) #1 | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28069958 | ELISA, WB | Serum | |
| Complement System | Factor P | Antibody | Human | A233 | Factor P Antibody (monoclonal) #1 | 2013 | https://pubmed.ncbi.nlm.nih.gov/22851705/ | FC | Serum | |
| Complement System | Factor P | Antibody | Human | A233 | Factor P Antibody (monoclonal) #1 | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22064712 | FC | Serum | Meningococcal infected |
| Complement System | Factor P | Antibody | Rabbit | A233 | Factor P Antibody (monoclonal) #1 | 2020 | https://pubmed.ncbi.nlm.nih.gov/32793201/ | Hemolytic Assay | Red Blood Cells | |
| Complement System | Factor P | Antibody | Human | A233 | Factor P Antibody (monoclonal) #1 | 2017 | https://pubmed.ncbi.nlm.nih.gov/27992410/ | WB | Plasma | SPIO nanoworms |
| Complement System | Factor P | Antibody | Human | A233 | Factor P Antibody (monoclonal) #1 | 2017 | https://pubmed.ncbi.nlm.nih.gov/27992410/ | WB | Serum | SPIO nanoworms |
| Complement System | Factor P | Antibody | Human | A233 | Factor P Antibody (monoclonal) #1 | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21878570 | WB | Serum | |
| Complement System | Factor P | Antibody | Human | A235 | Factor P Antibody (monoclonal) #2 | 2019 | https://pubmed.ncbi.nlm.nih.gov/31413105/ | ELISA | Whole Blood | Heme, various concentrations |
| Complement System | Factor P | Antibody | Human | A235 | Factor P Antibody (monoclonal) #2 | 2021 | https://pubmed.ncbi.nlm.nih.gov/34508573/ | ELISA | Plasma | |
| Complement System | Factor P | Antibody | Human | A235 | Factor P Antibody (monoclonal) #2 | 2021 | https://pubmed.ncbi.nlm.nih.gov/34858435/ | ELISA | Plasma | Congenital Thrombocytopenia |
| Complement System | Factor P | Antibody | Human | A235 | Factor P Antibody (monoclonal) #2 | 2021 | https://pubmed.ncbi.nlm.nih.gov/35003128/ | ELISA | Plasma | Heart Failure |
| Complement System | Factor P | Antibody | Human | A235 | Factor P Antibody (monoclonal) #2 | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27716448 | ELISA | Synovial fluid | |
| Complement System | Factor P | Antibody | Human | A235 | Factor P Antibody (monoclonal) #2 | 2014 | https://pubmed.ncbi.nlm.nih.gov/24797388/ | ELISA, Complement Activation Assay | Plasma | |
| Complement System | Factor P | Antibody | Human | A235 | Factor P Antibody (monoclonal) #2 | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28069958 | ELISA, WB | Serum | |
| Complement System | Factor P | Antibody | Human | A235 | Factor P Antibody (monoclonal) #2 | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21878570 | IF, FC | Serum | |
| Complement System | Vitronectin | Antibody | Human | A237 | Vitronectin Antibody (monoclonal) | 2006 | https://www.ncbi.nlm.nih.gov/pubmed/16907906 | ELISA | Serum | Systemic Lupus Erythematosus |
| Complement System | Vitronectin | Antibody | N/A | A237 | Vitronectin Antibody (monoclonal) | 2008 | https://www.ncbi.nlm.nih.gov/pubmed/18174166 | ELISA | Recombinant protein | |
| Complement System | Vitronectin | Antibody | Human | A237 | Vitronectin Antibody (monoclonal) | 2006 | https://www.ncbi.nlm.nih.gov/pubmed/16495531 | WB | Serum | Moraxella catarrhalis |
| Complement System | sC5b-9 | Antibody | Human | A239 | sC5b-9 Antibody (monoclonal - neoantigen) | 2021 | https://pubmed.ncbi.nlm.nih.gov/34796040/ | Complement Activation Assay, WB | Serum | |
| Complement System | sC5b-9 | Antibody | Human | A239 | sC5b-9 Antibody (monoclonal - neoantigen) | 2018 | https://pubmed.ncbi.nlm.nih.gov/30555486/ | ELISA | Serum | |
| Complement System | sC5b-9 | Antibody | Human | A239 | sC5b-9 Antibody (monoclonal - neoantigen) | 2020 | https://pubmed.ncbi.nlm.nih.gov/33615073/ | ELISA | Urine | Membranous Nephropathy |
| Complement System | sC5b-9 | Antibody | Human | A239 | sC5b-9 Antibody (monoclonal - neoantigen) | 2021 | https://pubmed.ncbi.nlm.nih.gov/34386659/ | ELISA | Plasma | Lupus Nephritis |
| Complement System | sC5b-9 | Antibody | Human | A239 | sC5b-9 Antibody (monoclonal - neoantigen) | 2021 | https://pubmed.ncbi.nlm.nih.gov/34440207/ | ELISA | Plasma | |
| Complement System | sC5b-9 | Antibody | Human | A239 | sC5b-9 Antibody (monoclonal - neoantigen) | 2022 | https://pubmed.ncbi.nlm.nih.gov/35493506/ | ELISA | Plasma | Antibody Mediated Rejection |
| Complement System | sC5b-9 | Antibody | Human | A239 | sC5b-9 Antibody (monoclonal - neoantigen) | 2022 | https://pubmed.ncbi.nlm.nih.gov/35958553/ | ELISA | Serum | CipA |
| Complement System | sC5b-9 | Antibody | Human | A239 | sC5b-9 Antibody (monoclonal - neoantigen) | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/19925495 | ELISA | Plasma | |
| Complement System | sC5b-9 | Antibody | Human | A239 | sC5b-9 Antibody (monoclonal - neoantigen) | 2018 | https://www.ncbi.nlm.nih.gov/pubmed/29632531 | ELISA | Serum | |
| Complement System | sC5b-9 | Antibody | Human | A239 | sC5b-9 Antibody (monoclonal - neoantigen) | 1998 | https://www.ncbi.nlm.nih.gov/pubmed/9687522 | ELISA | Amyloid-βeta peptides & NHS | |
| Complement System | sC5b-9 | Antibody | Human | A239 | sC5b-9 Antibody (monoclonal - neoantigen) | 2018 | https://pubmed.ncbi.nlm.nih.gov/29696019/ | ELISA, IF | Serum | HMGB1-coated microplates |
| Complement System | sC5b-9 | Antibody | Porcine | A239 | sC5b-9 Antibody (monoclonal - neoantigen) | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/26579969 | FC | Articular chondrocytes | |
| Complement System | sC5b-9 | Antibody | Rat | A239 | sC5b-9 Antibody (monoclonal - neoantigen) | 2008 | https://pubmed.ncbi.nlm.nih.gov/18578885/ | FC, IF | Spinal Cord Tissue | |
| Complement System | sC5b-9 | Antibody | Human | A239 | sC5b-9 Antibody (monoclonal - neoantigen) | 2008 | https://www.ncbi.nlm.nih.gov/pubmed/18783824 | IF | Placenta Tissue | |
| Complement System | sC5b-9 | Antibody | Bacteria | A239 | sC5b-9 Antibody (monoclonal - neoantigen) | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23320099 | IF | Borrelia valaisiana | |
| Complement System | sC5b-9 | Antibody | Bacteria | A239 | sC5b-9 Antibody (monoclonal - neoantigen) | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23943762 | IF | Borrelia burgdorferi | |
| Complement System | sC5b-9 | Antibody | Human | A239 | sC5b-9 Antibody (monoclonal - neoantigen) | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25658605 | IF | Skin Tissue | |
| Complement System | sC5b-9 | Antibody | Cell Culture | A239 | sC5b-9 Antibody (monoclonal - neoantigen) | 2020 | https://www.ncbi.nlm.nih.gov/pubmed/32054454 | IF | HNSCC Cells | |
| Complement System | sC5b-9 | Antibody | Human | A239 | sC5b-9 Antibody (monoclonal - neoantigen) | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/26457721 | IF, WB | Red Blood Cells | Plasmodium falciparum incubated |
| Complement System | sC5b-9 | Antibody | Cell Culture | A239 | sC5b-9 Antibody (monoclonal - neoantigen) | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/26457721 | IF, WB | Plasmodium falciparum culture | |
| Complement System | sC5b-9 | Antibody | Human | A239 | sC5b-9 Antibody (monoclonal - neoantigen) | 2020 | https://pubmed.ncbi.nlm.nih.gov/32936402/ | IHC | Spinal Cord Tissue | |
| Complement System | sC5b-9 | Antibody | Human | A239 | sC5b-9 Antibody (monoclonal - neoantigen) | 2021 | https://pubmed.ncbi.nlm.nih.gov/34169354/ | IHC | Disc Tissue | |
| Complement System | sC5b-9 | Antibody | Human | A239 | sC5b-9 Antibody (monoclonal - neoantigen) | 2021 | https://pubmed.ncbi.nlm.nih.gov/34201864/ | IHC | Placenta Tissue | |
| Complement System | sC5b-9 | Antibody | Rhesus Monkey | A239 | sC5b-9 Antibody (monoclonal - neoantigen) | 2005 | https://www.ncbi.nlm.nih.gov/pubmed/15992964 | IHC | Brain Tissue | |
| Complement System | sC5b-9 | Antibody | Human | A239 | sC5b-9 Antibody (monoclonal - neoantigen) | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25573909 | IHC | Kidney Tissue | Thrombotic Microangiopathy |
| Complement System | sC5b-9 | Antibody | Human | A239 | sC5b-9 Antibody (monoclonal - neoantigen) | 2005 | https://www.ncbi.nlm.nih.gov/pubmed/15908371 | Radiation Immunoassay | Serum | Haemophilus ducreyi incubated |
| Complement System | sC5b-9 | Antibody | Human | A239 | sC5b-9 Antibody (monoclonal - neoantigen) | 2006 | https://www.ncbi.nlm.nih.gov/pubmed/16495531 | WB | Serum | Moraxella catarrhalis |
| Complement System | Clusterin | Antibody | Human | A241 | Clusterin Antibody (monoclonal) | 2006 | https://www.ncbi.nlm.nih.gov/pubmed/16907906 | ELISA | Serum | Systemic Lupus Erythematosus |
| Complement System | C8 | Antibody | Human | A249 | C8 Antibody (monoclonal) | 2010 | https://pubmed.ncbi.nlm.nih.gov/20439477/ | WB | Serum | Neisseria gonorrhoeae |
| Complement System | C3d | Antibody | Human | A250 | C3d Antibody (monoclonal - neoantigen) | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/25205869 | ELISA | Serum | |
| Complement System | C3d | Antibody | Human | A250 | C3d Antibody (monoclonal - neoantigen) | 2014 | https://pubmed.ncbi.nlm.nih.gov/24038027/ | FC | Red Blood Cells | PNH |
| Complement System | C3d | Antibody | Human | A250 | C3d Antibody (monoclonal - neoantigen) | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28629435 | FC | Red Blood Cells | PNH |
| Complement System | C3d | Antibody | Rhesus Monkey | A250 | C3d Antibody (monoclonal - neoantigen) | 2005 | https://www.ncbi.nlm.nih.gov/pubmed/15992964 | IHC | Brain Tissue | |
| Complement System | C4d | Antibody | Human | A251 | C4d Antibody (monoclonal - neoantigen) | 2015 | https://pubmed.ncbi.nlm.nih.gov/25904443/ | Complement Activation Assay | EBC B Cells | |
| Complement System | C4d | Antibody | Rhesus Monkey | A251 | C4d Antibody (monoclonal - neoantigen) | 2005 | https://www.ncbi.nlm.nih.gov/pubmed/15992964 | IHC | Brain Tissue | |
| Complement System | Bb | Antibody | Human | A252 | Bb Antibody (monoclonal - neoantigen) | 1998 | https://www.ncbi.nlm.nih.gov/pubmed/9480984 | ELISA | Serum | |
| Complement System | Bb | Antibody | Human | A252 | Bb Antibody (monoclonal - neoantigen) | 2023 | https://pubmed.ncbi.nlm.nih.gov/37118504/ | ELISA | CSF | Alzheimer's Disease |
| Complement System | Bb | Antibody | Cell Culture | A252 | Bb Antibody (monoclonal - neoantigen) | 1998 | https://www.ncbi.nlm.nih.gov/pubmed/9748277 | ELISA, WB | COS-7 Cells | |
| Complement System | Bb | Antibody | Human | A252 | Bb Antibody (monoclonal - neoantigen) | 2022 | https://pubmed.ncbi.nlm.nih.gov/35491890/ | IHC | Kidney Tissue | Myeloperoxidase-ANCA-associated glomerulonephritis |
| Complement System | C4d | Antibody | Human | A253 | C4d Antibody (monoclonal) | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27146825 | ELISA | Serum | |
| Complement System | C4d | Antibody | Human | A253 | C4d Antibody (monoclonal) | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27716448 | ELISA | Synovial fluid | |
| Complement System | C4d | Antibody | Human | A253 | C4d Antibody (monoclonal) | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/29208014 | ELISA | Plasma | |
| Complement System | Factor H | Antibody | Human | A254 | Factor H Antibody (monoclonal) #2 | 2021 | https://pubmed.ncbi.nlm.nih.gov/34160562/ | ELISA | Eye Tissue | Age-Related Macular Degeneration |
| Complement System | Factor H | Antibody | Human | A254 | Factor H Antibody (monoclonal) #2 | 2021 | https://pubmed.ncbi.nlm.nih.gov/34912830/ | ELISA | Protein | Factor H WT and Variants |
| Complement System | Factor H | Antibody | Human | A254 | Factor H Antibody (monoclonal) #2 | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27572114 | ELISA | Purified Protein | |
| Complement System | Factor H | Antibody | Human | A254 | Factor H Antibody (monoclonal) #2 | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27572114 | ELISA | Serum | |
| Complement System | Factor H | Antibody | Human | A254 | Factor H Antibody (monoclonal) #2 | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25650401 | FC | Serum | N. gonorrhoeae incubated |
| Complement System | Factor H | Antibody | Plasmodium falciparum | A255 | Factor H Antibody (monoclonal) #3 | 2023 | https://pubmed.ncbi.nlm.nih.gov/37191558/ | IF | Cell Culture | Plasmodium falciparum |
| Complement System | C1-INH | Antibody | Human | A300 | C1-INH Antibody (polyclonal) | 2004 | https://www.ncbi.nlm.nih.gov/pubmed/15327690 | IF | Astrocyte cells | |
| Complement System | C1-INH | Antibody | Human | A300 | C1-INH Antibody (polyclonal) | 2004 | https://www.ncbi.nlm.nih.gov/pubmed/15327690 | IF | Microglial Cells | |
| Complement System | C1-INH | Antibody | Human | A300 | C1-INH Antibody (polyclonal) | 2004 | https://www.ncbi.nlm.nih.gov/pubmed/15327690 | IF | Oligodendrocyte cells | |
| Complement System | C1-INH | Antibody | Human | A300 | C1-INH Antibody (polyclonal) | 2010 | https://www.ncbi.nlm.nih.gov/pubmed/20408859 | Radial immunodiffusion | Serum | HIV |
| Complement System | C1-INH | Antibody | Human | A300 | C1-INH Antibody (polyclonal) | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/26654922 | Radial Immunodiffusion | Plasma | |
| Complement System | C1-INH | Antibody | Bacteria | A300 | C1-INH Antibody (polyclonal) | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23320099 | WB | Borrelia valaisiana | |
| Complement System | C1q | Antibody | N/A | A301 | C1q Antibody (polyclonal) | 2016 | https://pubmed.ncbi.nlm.nih.gov/26701312/ | ELISA | IVIg | Exposed to ferrous ions |
| Complement System | C1q | Antibody | Human | A301 | C1q Antibody (polyclonal) | 2021 | https://pubmed.ncbi.nlm.nih.gov/34160562/ | ELISA | Eye Tissue | Age-Related Macular Degeneration |
| Complement System | C1q | Antibody | Human | A301 | C1q Antibody (polyclonal) | 2022 | https://pubmed.ncbi.nlm.nih.gov/35874690/ | ELISA | Serum | |
| Complement System | C1q | Antibody | N/A | A301 | C1q Antibody (polyclonal) | 2010 | https://www.ncbi.nlm.nih.gov/pubmed/20120022 | ELISA | CD44 (coating) | |
| Complement System | C1q | Antibody | Human | A301 | C1q Antibody (polyclonal) | 2018 | https://www.ncbi.nlm.nih.gov/pubmed/29868022 | ELISA | Purified protein | |
| Complement System | C1q | Antibody | Human | A301 | C1q Antibody (polyclonal) | 2018 | https://www.ncbi.nlm.nih.gov/pubmed/30134810 | ELISA | Serum | Systemic Lupus Erythematosus |
| Complement System | C1q | Antibody | Human | A301 | C1q Antibody (polyclonal) | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22700724 | ELISA, IF, WB | Dendritic Cell | |
| Complement System | C1q | Antibody | Mouse | A301 | C1q Antibody (polyclonal) | 2010 | https://www.ncbi.nlm.nih.gov/pubmed/20352036 | IF | Microglial Cells | |
| Complement System | C1q | Antibody | Mouse | A301 | C1q Antibody (polyclonal) | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25762679 | IP | Brain Tissue | Cerebellum myelin substrate |
| Complement System | C1q | Antibody | Rat | A301 | C1q Antibody (polyclonal) | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28099414 | Neutralization | Protein Injection | |
| Complement System | C1q | Antibody | Human | A301 | C1q Antibody (polyclonal) | 2015 | https://pubmed.ncbi.nlm.nih.gov/26248865/ | WB | Serum | Acetyl salicylic acid dimer 5,5'-methylenebis(2-acetoxybenzoic acid) (DAS) |
| Complement System | C1q | Antibody | Human | A301 | C1q Antibody (polyclonal) | 2017 | https://pubmed.ncbi.nlm.nih.gov/29070672/ | WB | HeLa Cells | |
| Complement System | C1q | Antibody | Human | A301 | C1q Antibody (polyclonal) | 2006 | https://www.ncbi.nlm.nih.gov/pubmed/16495531 | WB | Serum | Moraxella catarrhalis |
| Complement System | C1q | Antibody | Cell Culture | A301 | C1q Antibody (polyclonal) | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27648302 | WB | Jurkat Cells | |
| Complement System | C1s | Antibody | Human | A302 | C1s Antibody (polyclonal) | 2019 | https://pubmed.ncbi.nlm.nih.gov/31320652/ | IF | Ovary Tissue | Follicular degeneration |
| Complement System | C1s | Antibody | Human | A302 | C1s Antibody (polyclonal) | 2016 | https://pubmed.ncbi.nlm.nih.gov/26831747/ | IHC | Breast Tissue, Colon Tissue, Lung Tissue, Pancreas Tissue, Skin Tissue | Malignant cancer |
| Complement System | C1s | Antibody | Human | A302 | C1s Antibody (polyclonal) | 2022 | https://pubmed.ncbi.nlm.nih.gov/35711467/ | IHC | Placenta Tissue | |
| Complement System | C1s | Antibody | Human, Mouse | A302 | C1s Antibody (polyclonal) | 2021 | https://pubmed.ncbi.nlm.nih.gov/18400300/ | WB | Purified protein | C1q |
| Complement System | C1s | Antibody | Human | A302 | C1s Antibody (polyclonal) | 2017 | https://pubmed.ncbi.nlm.nih.gov/29070672/ | WB | HeLa Cells | |
| Complement System | C1s | Antibody | Human, Mouse | A302 | C1s Antibody (polyclonal) | 2018 | https://pubmed.ncbi.nlm.nih.gov/29866771/ | WB | Plasma | Diabetes exosomes |
| Complement System | C1s | Antibody | Human | A302 | C1s Antibody (polyclonal) | 2021 | https://pubmed.ncbi.nlm.nih.gov/34502128/ | WB | Retina Tissue | |
| Complement System | C1s | Antibody | Mouse | A302 | C1s Antibody (polyclonal) | 2021 | https://pubmed.ncbi.nlm.nih.gov/34502128/ | WB | Eye Tissue | Retina, Sodium Iodate-Induced Degeneration |
| Complement System | C2 | Antibody | Human | A303 | C2 Antibody (Ig Fraction) (polyclonal) | 2006 | https://www.ncbi.nlm.nih.gov/pubmed/16734621 | WB | Serum | |
| Complement System | C2 | Antibody | Human | A303 | C2 Antibody (Ig Fraction) (polyclonal) | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21397947 | WB | Monocyte Derived Dendritic Cell | |
| Complement System | C3 | Antibody | Human | A304 | C3 Antibody (polyclonal) | 2008 | https://www.ncbi.nlm.nih.gov/pubmed/18167559 | ELISA | Serum | Ixodes ricinus incubated |
| Complement System | C3 | Antibody | Cell Culture | A304 | C3 Antibody (polyclonal) | 2021 | https://pubmed.ncbi.nlm.nih.gov/34489931/ | FC | ciGEnCs Cells | |
| Complement System | C3 | Antibody | Cell Culture | A304 | C3 Antibody (polyclonal) | 2021 | https://pubmed.ncbi.nlm.nih.gov/34489931/ | FC | HUVEC Cells | |
| Complement System | C3 | Antibody | Human | A304 | C3 Antibody (polyclonal) | 2006 | https://www.ncbi.nlm.nih.gov/pubmed/16495531 | FC, WB | Serum | Moraxella catarrhalis |
| Complement System | C3 | Antibody | Human | A304 | C3 Antibody (polyclonal) | 2021 | https://pubmed.ncbi.nlm.nih.gov/34440207/ | IF | Kidney Tissue | COVID-19 |
| Complement System | C3 | Antibody | Human | A304 | C3 Antibody (polyclonal) | 2021 | https://pubmed.ncbi.nlm.nih.gov/34440207/ | IF | Liver Tissue | COVID-19 |
| Complement System | C3 | Antibody | Human | A304 | C3 Antibody (polyclonal) | 2021 | https://pubmed.ncbi.nlm.nih.gov/34440207/ | IF | Lung Tissue | COVID-19 |
| Complement System | C3 | Antibody | Human | A304 | C3 Antibody (polyclonal) | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/26457721 | IF, WB | Red Blood Cells | Plasmodium falciparum incubated |
| Complement System | C3 | Antibody | Cell Culture | A304 | C3 Antibody (polyclonal) | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/26457721 | IF, WB | Plasmodium falciparum culture | |
| Complement System | C3 | Antibody | Human | A304 | C3 Antibody (polyclonal) | 2008 | https://www.ncbi.nlm.nih.gov/pubmed/18295334 | IHC | Decidual Endothelial Cells | |
| Complement System | C4 | Antibody | Human | A305 | C4 Antibody (polyclonal) | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25760458 | ELISA | Serum | Premolis semirufa caterpillar bristle extract |
| Complement System | C4 | Antibody | Human | A305 | C4 Antibody (polyclonal) | 2018 | https://www.ncbi.nlm.nih.gov/pubmed/30116749 | ELISA | Serum | B. lanceolatus venom |
| Complement System | C4 | Antibody | Human | A305 | C4 Antibody (polyclonal) | 2022 | https://pubmed.ncbi.nlm.nih.gov/36582241/ | IF | Kidney Tissue | Lupus Nephritis |
| Complement System | C4 | Antibody | Snake | A305 | C4 Antibody (polyclonal) | 2013 | https://pubmed.ncbi.nlm.nih.gov/24205428/ | Silver Stain | Bothrops pirajai venom | |
| Complement System | C4 | Antibody | Human | A305 | C4 Antibody (polyclonal) | 2019 | https://pubmed.ncbi.nlm.nih.gov/30601845/ | WB | Plasma | Chronic Lymphocytic Leukemia |
| Complement System | C4 | Antibody | Human | A305 | C4 Antibody (polyclonal) | 2006 | https://www.ncbi.nlm.nih.gov/pubmed/16495531 | WB | Serum | Moraxella catarrhalis |
| Complement System | C4 | Antibody | Human | A305 | C4 Antibody (polyclonal) | 2006 | https://www.ncbi.nlm.nih.gov/pubmed/16556262 | WB | Serum | Escherichia coli incubated |
| Complement System | C5 | Antibody | Human | A306 | C5 Antibody (polyclonal) | 1998 | https://pubmed.ncbi.nlm.nih.gov/9712784/ | Complement Activation Assay | Polymorphonuclear Cells | Cryptococcus neoformans |
| Complement System | C5 | Antibody | Human | A306 | C5 Antibody (polyclonal) | 2016 | https://pubmed.ncbi.nlm.nih.gov/27638863/ | ELISA | Serum | |
| Complement System | C5 | Antibody | Human | A306 | C5 Antibody (polyclonal) | 2019 | https://pubmed.ncbi.nlm.nih.gov/31263464/ | ELISA | Plasma | |
| Complement System | C5 | Antibody | Human | A306 | C5 Antibody (polyclonal) | 2019 | https://pubmed.ncbi.nlm.nih.gov/31263464/ | ELISA | Serum | |
| Complement System | C5 | Antibody | Human | A306 | C5 Antibody (polyclonal) | 2022 | https://pubmed.ncbi.nlm.nih.gov/35493506/ | IHC | Kidney Tissue | Antibody Mediated Rejection |
| Complement System | C5 | Antibody | Rhesus Monkey | A306 | C5 Antibody (polyclonal) | 2005 | https://www.ncbi.nlm.nih.gov/pubmed/15992964 | IHC | Brain Tissue | |
| Complement System | C5 | Antibody | Mouse | A306 | C5 Antibody (polyclonal) | 2020 | https://pubmed.ncbi.nlm.nih.gov/32376801/ | WB | Plasma | |
| Complement System | C5 | Antibody | Mouse | A306 | C5 Antibody (polyclonal) | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23184055 | WB | Plasma | |
| Complement System | C5 | Antibody | Bacteria | A306 | C5 Antibody (polyclonal) | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23320099 | WB | Borrelia valaisiana | |
| Complement System | C5 | Antibody | Mouse | A306 | C5 Antibody (polyclonal) | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/24279761 | WB | Plasma | |
| Complement System | C5 | Antibody | Mouse | A306 | C5 Antibody (polyclonal) | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27564415 | WB | Plasma | |
| Complement System | C6 | Antibody | Human | A307 | C6 Antibody (polyclonal) | 2015 | https://pubmed.ncbi.nlm.nih.gov/26248865/ | ELISA, WB | Serum | Acetyl salicylic acid dimer 5,5'-methylenebis(2-acetoxybenzoic acid) (DAS) |
| Complement System | C6 | Antibody | Bacteria | A307 | C6 Antibody (polyclonal) | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23943762 | IF | Borrelia burgdorferi | |
| Complement System | C6 | Antibody | Human | A307 | C6 Antibody (polyclonal) | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/24489894 | WB | Red Blood Cells | PNH |
| Complement System | C7 | Antibody | Human | A308 | C7 Antibody (polyclonal) | 2015 | https://pubmed.ncbi.nlm.nih.gov/26248865/ | ELISA, WB | Serum | Acetyl salicylic acid dimer 5,5'-methylenebis(2-acetoxybenzoic acid) (DAS) |
| Complement System | C7 | Antibody | Bacteria | A308 | C7 Antibody (polyclonal) | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23943762 | IF | Borrelia burgdorferi | |
| Complement System | C7 | Antibody | Human | A308 | C7 Antibody (polyclonal) | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/19221116 | Radial immunodiffusion | Plasma | |
| Complement System | C7 | Antibody | Human | A308 | C7 Antibody (polyclonal) | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/19221116 | Radial immunodiffusion | Serum | |
| Complement System | C7 | Antibody | Human | A308 | C7 Antibody (polyclonal) | 2006 | https://www.ncbi.nlm.nih.gov/pubmed/16495531 | WB | Serum | Moraxella catarrhalis |
| Complement System | C8 | Antibody | Human | A309 | C8 Antibody (polyclonal) | 2015 | https://pubmed.ncbi.nlm.nih.gov/26248865/ | ELISA, WB | Serum | Acetyl salicylic acid dimer 5,5'-methylenebis(2-acetoxybenzoic acid) (DAS) |
| Complement System | C8 | Antibody | Human | A309 | C8 Antibody (polyclonal) | 2010 | https://pubmed.ncbi.nlm.nih.gov/20428236/ | IF | Eye Tissue | Drusen |
| Complement System | C8 | Antibody | Bacteria | A309 | C8 Antibody (polyclonal) | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23943762 | IF | Borrelia burgdorferi | |
| Complement System | C8 | Antibody | Mouse | A309 | C8 Antibody (polyclonal) | 2009 | https://pubmed.ncbi.nlm.nih.gov/19038499/ | IF, IHC | Muscle | Trichinella spiralis |
| Complement System | C8 | Antibody | Human | A309 | C8 Antibody (polyclonal) | 2016 | https://pubmed.ncbi.nlm.nih.gov/27183977/ | WB | Serum | C8 Deficient w/Invasive meningococcal disease |
| Complement System | C9 | Antibody | Human | A310 | C9 Antibody (polyclonal) | 2015 | https://pubmed.ncbi.nlm.nih.gov/26248865/ | ELISA, WB | Serum | Acetyl salicylic acid dimer 5,5'-methylenebis(2-acetoxybenzoic acid) (DAS) |
| Complement System | C9 | Antibody | Human | A310 | C9 Antibody (polyclonal) | 2006 | https://www.ncbi.nlm.nih.gov/pubmed/17052351 | ICC, IHC | Brain Tissue | |
| Complement System | C9 | Antibody | Human | A310 | C9 Antibody (polyclonal) | 2008 | https://www.ncbi.nlm.nih.gov/pubmed/18334032 | ICC, IHC | Brain Tissue | |
| Complement System | C9 | Antibody | Bacteria | A310 | C9 Antibody (polyclonal) | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23943762 | IF | Borrelia burgdorferi | |
| Complement System | C9 | Antibody | Mouse | A310 | C9 Antibody (polyclonal) | 2009 | https://pubmed.ncbi.nlm.nih.gov/19038499/ | IF, IHC | Muscle | Trichinella spiralis |
| Complement System | C9 | Antibody | Rhesus Monkey | A310 | C9 Antibody (polyclonal) | 2005 | https://www.ncbi.nlm.nih.gov/pubmed/15992964 | IHC | Brain Tissue | |
| Complement System | C9 | Antibody | Human | A310 | C9 Antibody (polyclonal) | 2010 | https://www.ncbi.nlm.nih.gov/pubmed/20408859 | Radial immunodiffusion | Serum | HIV |
| Complement System | Factor B | Antibody | Human | A311 | Factor B Antibody (polyclonal) | 2022 | https://pubmed.ncbi.nlm.nih.gov/35874690/ | ELISA | Serum | |
| Complement System | Factor B | Antibody | Human | A311 | Factor B Antibody (polyclonal) | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25650401 | ELISA | Serum | N. gonorrhoeae incubated |
| Complement System | Factor B | Antibody | Human | A311 | Factor B Antibody (polyclonal) | 2008 | https://www.ncbi.nlm.nih.gov/pubmed/18167559 | ELISA, WB | Red Blood Cells | Ixodes ricinus incubated |
| Complement System | Factor B | Antibody | Mouse | A311 | Factor B Antibody (polyclonal) | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21502587 | IF, WB | Bone Tissue | Temporal Bone |
| Complement System | Factor B | Antibody | Mouse | A311 | Factor B Antibody (polyclonal) | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21502587 | IF, WB | Middle Ear Fluid | |
| Complement System | Factor B | Antibody | Cell Culture | A311 | Factor B Antibody (polyclonal) | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23537925 | IF, WB | HMEE Cells | |
| Complement System | Factor B | Antibody | Mouse | A311 | Factor B Antibody (polyclonal) | 2021 | https://pubmed.ncbi.nlm.nih.gov/34867198/ | IHC | Eye Tissue | |
| Complement System | Factor B | Antibody | Bacteria | A311 | Factor B Antibody (polyclonal) | 2016 | https://pubmed.ncbi.nlm.nih.gov/27638863/ | WB | Filifactor alocis | |
| Complement System | Factor B | Antibody | Human | A311 | Factor B Antibody (polyclonal) | 2016 | https://pubmed.ncbi.nlm.nih.gov/27659908/ | WB | ARPE-19 cells | |
| Complement System | Factor B | Antibody | Mouse | A311 | Factor B Antibody (polyclonal) | 2020 | https://pubmed.ncbi.nlm.nih.gov/32376801/ | WB | Plasma | |
| Complement System | Factor B | Antibody | Human | A311 | Factor B Antibody (polyclonal) | 2021 | https://pubmed.ncbi.nlm.nih.gov/34502128/ | WB | Retina Tissue | |
| Complement System | Factor B | Antibody | Mouse | A311 | Factor B Antibody (polyclonal) | 2021 | https://pubmed.ncbi.nlm.nih.gov/34502128/ | WB | Eye Tissue | Retina, Sodium Iodate-Induced Degeneration |
| Complement System | Factor B | Antibody | Mouse | A311 | Factor B Antibody (polyclonal) | 2022 | https://pubmed.ncbi.nlm.nih.gov/35943778/ | WB | Eye Tissue | |
| Complement System | Factor B | Antibody | Bacteria | A311 | Factor B Antibody (polyclonal) | 2022 | https://pubmed.ncbi.nlm.nih.gov/35958553/ | WB | A. baumannii | |
| Complement System | Factor B | Antibody | Human | A311 | Factor B Antibody (polyclonal) | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21397947 | WB | Monocyte Derived Dendritic Cell | |
| Complement System | Factor B | Antibody | Mouse | A311 | Factor B Antibody (polyclonal) | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/24279761 | WB | Plasma | |
| Complement System | Factor B | Antibody | Mouse | A311 | Factor B Antibody (polyclonal) | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27564415 | WB | Plasma | |
| Complement System | Factor H | Antibody | Human | A312 | Factor H Antibody (polyclonal) | 2019 | https://pubmed.ncbi.nlm.nih.gov/31263464/ | ELISA | Plasma | |
| Complement System | Factor H | Antibody | Human | A312 | Factor H Antibody (polyclonal) | 2019 | https://pubmed.ncbi.nlm.nih.gov/31263464/ | ELISA | Serum | |
| Complement System | Factor H | Antibody | Human | A312 | Factor H Antibody (polyclonal) | 2021 | https://pubmed.ncbi.nlm.nih.gov/34193601/ | ELISA | Purified protein | |
| Complement System | Factor H | Antibody | Human | A312 | Factor H Antibody (polyclonal) | 2021 | https://pubmed.ncbi.nlm.nih.gov/34260947/ | ELISA | Serum | Age-Related Macular Degeneration |
| Complement System | Factor H | Antibody | Human | A312 | Factor H Antibody (polyclonal) | 2021 | https://pubmed.ncbi.nlm.nih.gov/34508573/ | ELISA | Plasma | |
| Complement System | Factor H | Antibody | Human | A312 | Factor H Antibody (polyclonal) | 2021 | https://pubmed.ncbi.nlm.nih.gov/34912830/ | ELISA | Protein | Factor H WT and Variants |
| Complement System | Factor H | Antibody | N/A | A312 | Factor H Antibody (polyclonal) | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/18962898 | ELISA | Purified protein | SLRP |
| Complement System | Factor H | Antibody | Human | A312 | Factor H Antibody (polyclonal) | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23596522 | ELISA | Purified protein | |
| Complement System | Factor H | Antibody | Bacteria | A312 | Factor H Antibody (polyclonal) | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27399785 | ELISA | Streptococcus suis | |
| Complement System | Factor H | Antibody | Human | A312 | Factor H Antibody (polyclonal) | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27572114 | ELISA | Purified Protein | |
| Complement System | Factor H | Antibody | Human | A312 | Factor H Antibody (polyclonal) | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27572114 | ELISA | Serum | |
| Complement System | Factor H | Antibody | Mouse | A312 | Factor H Antibody (polyclonal) | 2020 | https://pubmed.ncbi.nlm.nih.gov/32849636/ | ELISA, IF, WB | Kidney Tissue | |
| Complement System | Factor H | Antibody | Mouse | A312 | Factor H Antibody (polyclonal) | 2020 | https://pubmed.ncbi.nlm.nih.gov/32849636/ | ELISA, IF, WB | Plasma | |
| Complement System | Factor H | Antibody | Mouse | A312 | Factor H Antibody (polyclonal) | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/26729803 | ELISA, WB | Kidney Tissue | |
| Complement System | Factor H | Antibody | Mouse | A312 | Factor H Antibody (polyclonal) | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/26729803 | ELISA, WB | Plasma | |
| Complement System | Factor H | Antibody | Bacteria | A312 | Factor H Antibody (polyclonal) | 2018 | https://pubmed.ncbi.nlm.nih.gov/29535198/ | FC | Streptococcus pneumoniae | |
| Complement System | Factor H | Antibody | Human | A312 | Factor H Antibody (polyclonal) | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/24092930 | FC | Endothelial Cells | Microparticles incubation |
| Complement System | Factor H | Antibody | Human | A312 | Factor H Antibody (polyclonal) | 2008 | https://www.ncbi.nlm.nih.gov/pubmed/17915330 | FC, IF | Plasma | Aspergillus incubated |
| Complement System | Factor H | Antibody | Human | A312 | Factor H Antibody (polyclonal) | 2019 | https://pubmed.ncbi.nlm.nih.gov/31270173/ | Hemolytic Assay | Serum | |
| Complement System | Factor H | Antibody | Human | A312 | Factor H Antibody (polyclonal) | 2019 | https://pubmed.ncbi.nlm.nih.gov/30692699/ | IF | Choroid plexus Tissue | |
| Complement System | Factor H | Antibody | Human | A312 | Factor H Antibody (polyclonal) | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/26091360 | IF, WB | ARPE-19 cells | |
| Complement System | Factor H | Antibody | Human | A312 | Factor H Antibody (polyclonal) | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25887232 | IHC | Kidney Tissue | |
| Complement System | Factor H | Antibody | Bacteria | A312 | Factor H Antibody (polyclonal) | 2022 | https://pubmed.ncbi.nlm.nih.gov/35303742/ | WB | Borrelia hermsii | |
| Complement System | Factor H | Antibody | Rat | A312 | Factor H Antibody (polyclonal) | 2007 | https://www.ncbi.nlm.nih.gov/pubmed/17490866 | WB | Hepatocytes | |
| Complement System | Factor H | Antibody | Rat | A312 | Factor H Antibody (polyclonal) | 2007 | https://www.ncbi.nlm.nih.gov/pubmed/17490866 | WB | Kupffer cells | |
| Complement System | Factor H | Antibody | Mouse | A312 | Factor H Antibody (polyclonal) | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/19411110 | WB | Serum | |
| Complement System | Factor H | Antibody | Human | A312 | Factor H Antibody (polyclonal) | 2010 | https://www.ncbi.nlm.nih.gov/pubmed/20538296 | WB | Plasma | |
| Complement System | Factor H | Antibody | Human | A312 | Factor H Antibody (polyclonal) | 2010 | https://www.ncbi.nlm.nih.gov/pubmed/21057332 | WB | Plasma | |
| Complement System | Factor H | Antibody | Human | A312 | Factor H Antibody (polyclonal) | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21397947 | WB | Monocyte Derived Dendritic Cell | |
| Complement System | Factor H | Antibody | Mouse | A312 | Factor H Antibody (polyclonal) | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21544060 | WB | Serum | |
| Complement System | Factor H | Antibody | Cell Culture | A312 | Factor H Antibody (polyclonal) | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23760402 | WB | CLL Cells | |
| Complement System | Factor H | Antibody | Mouse | A312 | Factor H Antibody (polyclonal) | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27564415 | WB | Plasma | |
| Complement System | Factor I | Antibody | Human | A313 | Factor I Antibody (polyclonal) | 2021 | https://pubmed.ncbi.nlm.nih.gov/35935964/ | ELISA | Plasma | Sickel Cell Anemia |
| Complement System | Factor I | Antibody | Bacteria | A313 | Factor I Antibody (polyclonal) | 2022 | https://pubmed.ncbi.nlm.nih.gov/35958553/ | WB | A. baumannii | |
| Complement System | Factor I | Antibody | Mouse | A313 | Factor I Antibody (polyclonal) | 2008 | https://www.ncbi.nlm.nih.gov/pubmed/18202746 | WB | Serum | |
| Complement System | Factor I | Antibody | Human | A313 | Factor I Antibody (polyclonal) | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21397947 | WB | Monocyte Derived Dendritic Cell | |
| Complement System | C1q | Protein | Human | A400 | C1q Protein | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/26047793 | Binding Assay | Serum | dnDSA |
| Complement System | C1q | Protein | Cell Culture | A400 | C1q Protein | 2018 | https://www.ncbi.nlm.nih.gov/pubmed/29559654 | Cell Migration Assay | HepG2 cells | |
| Complement System | C1q | Protein | Human | A400 | C1q Protein | 2010 | https://www.ncbi.nlm.nih.gov/pubmed/20456695 | Chemotaxis Assay | Hematopoietic stem/progenitor cells | |
| Complement System | C1q | Protein | Cell Culture | A400 | C1q Protein | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22577035 | Complement Activation Assay | C57BL/6 | Bone marrow cells |
| Complement System | C1q | Protein | Sheep | A400 | C1q Protein | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25429660 | Complement Activation Assay | Red Blood Cells | |
| Complement System | C1q | Protein | Rat | A400 | C1q Protein | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/26728245 | Complement Activation Assay | Protein Injection | |
| Complement System | C1q | Protein | N/A | A400 | C1q Protein | 2006 | https://www.ncbi.nlm.nih.gov/pubmed/16907906 | ELISA | Purified protein | Standard curve generation |
| Complement System | C1q | Protein | Hamster | A400 | C1q Protein | 2008 | https://www.ncbi.nlm.nih.gov/pubmed/18313756 | ELISA | CHO Cells | pEE-QuVHVL Transfected |
| Complement System | C1q | Protein | N/A | A400 | C1q Protein | 2008 | https://www.ncbi.nlm.nih.gov/pubmed/18560159 | ELISA | C1q Protein | |
| Complement System | C1q | Protein | N/A | A400 | C1q Protein | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/19180241 | ELISA | C1q Protein | |
| Complement System | C1q | Protein | Human | A400 | C1q Protein | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/19707565 | ELISA | Plasma | Dengue |
| Complement System | C1q | Protein | N/A | A400 | C1q Protein | 2010 | https://www.ncbi.nlm.nih.gov/pubmed/20120022 | ELISA | CD44 (coating) | |
| Complement System | C1q | Protein | Human | A400 | C1q Protein | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21397947 | ELISA | Dendritic Cell | |
| Complement System | C1q | Protein | Human | A400 | C1q Protein | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22203857 | ELISA | Extravillous trophoblast cells | |
| Complement System | C1q | Protein | N/A | A400 | C1q Protein | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22531441 | ELISA | CD-20 Antibody (AbX) | |
| Complement System | C1q | Protein | N/A | A400 | C1q Protein | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22811680 | ELISA | rSALSA | |
| Complement System | C1q | Protein | Human | A400 | C1q Protein | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22933620 | ELISA | IgG Antibody | IgG-APS, IgG-MHS, IgM-APS, IgM-NHS |
| Complement System | C1q | Protein | N/A | A400 | C1q Protein | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23667612 | ELISA | PAT-SM6 Antibody (coating) | |
| Complement System | C1q | Protein | Human | A400 | C1q Protein | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27606571 | ELISA | Serum | Anti-hinge antibodies |
| Complement System | C1q | Protein | Human | A400 | C1q Protein | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28077575 | ELISA | C1q Protein | Binding Assay |
| Complement System | C1q | Protein | Human | A400 | C1q Protein | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/28082982 | ELISA | Serum | |
| Complement System | C1q | Protein | Human | A400 | C1q Protein | 2018 | https://www.ncbi.nlm.nih.gov/pubmed/29531170 | ELISA | Serum | Fc activation |
| Complement System | C1q | Protein | Human | A400 | C1q Protein | 2018 | https://www.ncbi.nlm.nih.gov/pubmed/29868022 | ELISA | Purified protein | |
| Complement System | C1q | Protein | Human | A400 | C1q Protein | 2018 | https://www.ncbi.nlm.nih.gov/pubmed/29895567 | ELISA | Serum | Immune Complexes |
| Complement System | C1q | Protein | Mouse | A400 | C1q Protein | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25762679 | ELISA, IP | Brain Tissue | Cerebellum myelin substrate |
| Complement System | C1q | Protein | Human | A400 | C1q Protein | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21637332 | FC | Peripheral blood mononuclear cells | |
| Complement System | C1q | Protein | Human | A400 | C1q Protein | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23238564 | FC | Thymocyte Cells | |
| Complement System | C1q | Protein | Human | A400 | C1q Protein | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/19484134 | IF | Prostate Tissue | |
| Complement System | C1q | Protein | Cell Culture | A400 | C1q Protein | 2020 | https://www.ncbi.nlm.nih.gov/pubmed/32054454 | IF | HNSCC Cells | |
| Complement System | C1q | Protein | Human | A400 | C1q Protein | 2021 | https://pubmed.ncbi.nlm.nih.gov/34381048/ | Protein Assay | Plasma | |
| Complement System | C1q | Protein | Human | A400 | C1q Protein | 2008 | https://www.ncbi.nlm.nih.gov/pubmed/18295334 | WB | Purified protein | |
| Complement System | C3 | Protein | Cell Culture | A401 | C3 Protein | 2021 | https://pubmed.ncbi.nlm.nih.gov/35052426/ | Binding Assay | MDA-MB-231 Cells | |
| Complement System | C3 | Protein | Human | A401 | C3 Protein | 2022 | https://pubmed.ncbi.nlm.nih.gov/36605203/ | Complement Activation Assay | HBE Cells | Cigarette smoke-induced oxidative stress |
| Complement System | C3 | Protein | Human | A401 | C3 Protein | 2017 | https://pubmed.ncbi.nlm.nih.gov/27992410/ | Dot Blot | Serum | SPIO nanoworms |
| Complement System | C3 | Protein | N/A | A401 | C3 Protein | 2006 | https://www.ncbi.nlm.nih.gov/pubmed/16907906 | ELISA | Purified protein | Standard curve generation |
| Complement System | C3 | Protein | Human | A401 | C3 Protein | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/19707565 | ELISA | Plasma | Dengue |
| Complement System | C3 | Protein | Human | A401 | C3 Protein | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21397947 | ELISA | Dendritic Cell | |
| Complement System | C3 | Protein | Human | A401 | C3 Protein | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21598302 | ELISA | Peripheral blood mononuclear cells | |
| Complement System | C3 | Protein | Mouse | A401 | C3 Protein | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25762679 | ELISA | Brain Tissue | Cerebellum myelin substrate |
| Complement System | C3 | Protein | Human | A401 | C3 Protein | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28069958 | ELISA | Serum | |
| Complement System | C3 | Protein | Mouse | A401 | C3 Protein | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/29018286 | ELISA | Neuron Cells | |
| Complement System | C3 | Protein | Human | A401 | C3 Protein | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/29245944 | ELISA | HUVEC Cells | KSHV infection |
| Complement System | C3 | Protein | Premolis semirufa (Caterpillar) | A401 | C3 Protein | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25760458 | Silver Stain | Bristle Extract | |
| Complement System | C3 | Protein | Human | A401 | C3 Protein | 2018 | https://www.ncbi.nlm.nih.gov/pubmed/30116749 | Silver Stain | Purified protein | B. lanceolatus venom incubated |
| Complement System | C3 | Protein | Snake | A401 | C3 Protein | 2013 | https://pubmed.ncbi.nlm.nih.gov/24205428/ | Silver Stain | Bothrops pirajai venom | |
| Complement System | C3 | Protein | N/A | A401 | C3 Protein | 2021 | https://pubmed.ncbi.nlm.nih.gov/34489939/ | WB | Control | |
| Complement System | C3 | Protein | Human | A401 | C3 Protein | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/24983375 | WB | Serum | |
| Complement System | C3 | Protein | N/A | A401 | C3 Protein | 1996 | https://www.ncbi.nlm.nih.gov/pubmed/8670328 | WB | C3 Protein | |
| Complement System | C4 | Protein | Human | A402 | C4 Protein | 2021 | https://pubmed.ncbi.nlm.nih.gov/34381048/ | ELISA | Plasma | |
| Complement System | C4 | Protein | N/A | A402 | C4 Protein | 2006 | https://www.ncbi.nlm.nih.gov/pubmed/16907906 | ELISA | Purified protein | Standard curve generation |
| Complement System | C4 | Protein | Human | A402 | C4 Protein | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21397947 | ELISA | Dendritic Cell | |
| Complement System | C4 | Protein | Premolis semirufa (Caterpillar) | A402 | C4 Protein | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25760458 | Silver Stain | Bristle Extract | |
| Complement System | C4 | Protein | Human | A402 | C4 Protein | 2018 | https://www.ncbi.nlm.nih.gov/pubmed/30116749 | Silver Stain | Purified protein | B. lanceolatus venom incubated |
| Complement System | C4 | Protein | Snake | A402 | C4 Protein | 2013 | https://pubmed.ncbi.nlm.nih.gov/24205428/ | Silver Stain | Bothrops pirajai venom | |
| Complement System | C5 | Protein | Human | A403 | C5 Protein | 2019 | https://pubmed.ncbi.nlm.nih.gov/30601845/ | ELISA | Plasma | Chronic Lymphocytic Leukemia |
| Complement System | C5 | Protein | Human | A403 | C5 Protein | 2019 | https://pubmed.ncbi.nlm.nih.gov/30601845/ | ELISA | Serum | Chronic Lymphocytic Leukemia |
| Complement System | C5 | Protein | Human | A403 | C5 Protein | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21598302 | ELISA | Peripheral blood mononuclear cells | |
| Complement System | C5 | Protein | Human | A403 | C5 Protein | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25706641 | Microarray | Whole Blood | |
| Complement System | C5 | Protein | Premolis semirufa (Caterpillar) | A403 | C5 Protein | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25760458 | Silver Stain | Bristle Extract | |
| Complement System | C5 | Protein | Human | A403 | C5 Protein | 2018 | https://www.ncbi.nlm.nih.gov/pubmed/30116749 | Silver Stain | Purified protein | B. lanceolatus venom incubated |
| Complement System | C5 | Protein | Snake | A403 | C5 Protein | 2013 | https://pubmed.ncbi.nlm.nih.gov/24205428/ | Silver Stain | Bothrops pirajai venom | |
| Complement System | C5 | Protein | Human | A403 | C5 Protein | 2021 | https://pubmed.ncbi.nlm.nih.gov/34380648/ | WB | Purified protein | |
| Complement System | C6 | Protein | Cell Culture | A404 | C6 Protein | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28632844 | WB | RPE Cells | |
| Complement System | C7 | Protein | Human | A405 | C7 Protein | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22202123 | Bacterial plating | Serum | C7 Depleted |
| Complement System | C7 | Protein | Human | A405 | C7 Protein | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/19386604 | TER Measurements | ARPE-19 Cells | |
| Complement System | C9 | Protein | Cell Culture | A405 | C7 Protein | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22408008 | TER Measurements | RPE Cells | |
| Complement System | C9 | Protein | Cell Culture | A407 | C9 Protein | 2021 | https://pubmed.ncbi.nlm.nih.gov/34489931/ | FC | ciGEnCs Cells | |
| Complement System | C9 | Protein | Cell Culture | A407 | C9 Protein | 2021 | https://pubmed.ncbi.nlm.nih.gov/34489931/ | FC | HUVEC Cells | |
| Complement System | C9 | Protein | Human | A407 | C9 Protein | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27703454 | Lysis assay | Serum | C9 deficient and EA cells incubated |
| Complement System | Factor B | Protein | Human | A408 | Factor B Protein | 2017 | https://pubmed.ncbi.nlm.nih.gov/27992410/ | Dot Blot | Serum | SPIO nanoworms |
| Complement System | Factor B | Protein | Human | A408 | Factor B Protein | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/29245944 | ELISA | HUVEC Cells | KSHV infection |
| Complement System | Factor D | Protein | Human | A409 | Factor D Protein | 2017 | https://pubmed.ncbi.nlm.nih.gov/27992410/ | Dot Blot | Serum | SPIO nanoworms |
| Complement System | Factor D | Protein | Human | A409 | Factor D Protein | 2015 | https://pubmed.ncbi.nlm.nih.gov/26248865/ | ELISA, WB | Serum | Acetyl salicylic acid dimer 5,5'-methylenebis(2-acetoxybenzoic acid) (DAS) |
| Complement System | Factor H | Protein | Human | A410 | Factor H Protein | 2021 | https://pubmed.ncbi.nlm.nih.gov/34381048/ | ELISA | Plasma | |
| Complement System | Factor H | Protein | Human | A410 | Factor H Protein | 2006 | https://www.ncbi.nlm.nih.gov/pubmed/16412054 | ELISA | Plasma | |
| Complement System | Factor H | Protein | Human | A410 | Factor H Protein | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21860027 | ELISA | Serum | |
| Complement System | Factor H | Protein | Bacteria | A410 | Factor H Protein | 2010 | https://www.ncbi.nlm.nih.gov/pubmed/20194599 | ELISA, FC | Streptococcus pneumoniae | |
| Complement System | Factor H | Protein | Human, Mouse | A410 | Factor H Protein | 2021 | https://pubmed.ncbi.nlm.nih.gov/34139209/ | IF | Kidney Tissue | |
| Complement System | Factor H | Protein | N/A | A410 | Factor H Protein | 2018 | https://pubmed.ncbi.nlm.nih.gov/29535198/ | WB | Protein | PspC |
| Complement System | Factor H | Protein | Cell Culture | A410 | Factor H Protein | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23760402 | WB | CLL Cells | |
| Complement System | Factor H | Protein | Plasmodium falciparum | A410 | Factor H Protein | 2023 | https://pubmed.ncbi.nlm.nih.gov/37191558/ | WB | Cell Culture | Plasmodium falciparum |
| Complement System | Factor I | Protein | Human | A411 | Factor I Protein | 2021 | https://pubmed.ncbi.nlm.nih.gov/34381048/ | ELISA | Plasma | |
| Complement System | Factor I | Protein | Human | A411 | Factor I Protein | 2006 | https://www.ncbi.nlm.nih.gov/pubmed/16412054 | ELISA | Plasma | |
| Complement System | Factor P | Protein | Mouse | A412 | Factor P Protein | 2014 | https://pubmed.ncbi.nlm.nih.gov/24797388/ | Antibody generation | Balb/c | |
| Complement System | Factor P | Protein | Human | A412 | Factor P Protein | 2017 | https://pubmed.ncbi.nlm.nih.gov/27992410/ | Dot Blot | Serum | SPIO nanoworms |
| Complement System | Factor P | Protein | Human | A412 | Factor P Protein | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/29245944 | ELISA | HUVEC Cells | KSHV infection |
| Complement System | Factor P | Protein | Human | A412 | Factor P Protein | 2015 | https://pubmed.ncbi.nlm.nih.gov/26248865/ | ELISA, WB | Serum | Acetyl salicylic acid dimer 5,5'-methylenebis(2-acetoxybenzoic acid) (DAS) |
| Complement System | sC5b-9 | Protein | Human | A415 | SC5b-9 Protein | 2018 | https://pubmed.ncbi.nlm.nih.gov/30555486/ | ELISA | Serum | |
| Complement System | C3c | Protein | Cell Culture | A417 | C3c Protein | 2021 | https://pubmed.ncbi.nlm.nih.gov/35052426/ | Binding Assay | MDA-MB-231 Cells | |
| Complement System | iC3b | Protein | Cell Culture | A423 | iC3b Protein | 2021 | https://pubmed.ncbi.nlm.nih.gov/35052426/ | Binding Assay | MDA-MB-231 Cells | |
| Complement System | C1-INH | Protein | Human | A426 | C1-INH Protein | 2018 | https://www.ncbi.nlm.nih.gov/pubmed/30116749 | Silver Stain | Purified protein | B. lanceolatus venom incubated |
| Complement System | C1-INH | Protein | Snake | A426 | C1-INH Protein | 2013 | https://pubmed.ncbi.nlm.nih.gov/24205428/ | Silver Stain | Bothrops pirajai venom | |
| Complement System | C1-INH | Protein | Human | A426 | C1-INH Protein | 2015 | https://pubmed.ncbi.nlm.nih.gov/26248865/ | WB | Serum | Acetyl salicylic acid dimer 5,5'-methylenebis(2-acetoxybenzoic acid) (DAS) |
| Complement System | C2 | Protein | Human | A427 | C2 Protein | 2021 | https://pubmed.ncbi.nlm.nih.gov/34381048/ | ELISA | Plasma | |
| Complement System | C2 | Depleted Sera | Human | A500 | C2 Depleted Sera | 2021 | https://pubmed.ncbi.nlm.nih.gov/34381048/ | ELISA | Plasma | |
| Complement System | C5 | Depleted Sera | Cell Culture | A501 | C5 Depleted Sera | 2017 | https://pubmed.ncbi.nlm.nih.gov/28634480/ | CDC Assay | Raji cells | |
| Complement System | C5 | Depleted Sera | Cell Culture | A501 | C5 Depleted Sera | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/19019965 | Complement Activation Assay | Vero E6 cells | |
| Complement System | C6 | Depleted Sera | Cell Culture | A502 | C6 Depleted Sera | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/25254972 | Cell Culture | TIME-KSHV cells | |
| Complement System | C6 | Depleted Sera | Human | A502 | C6 Depleted Sera | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/29245944 | ELISA | HUVEC Cells | KSHV infection |
| Complement System | C6 | Depleted Sera | Cell Culture | A502 | C6 Depleted Sera | 1992 | https://www.ncbi.nlm.nih.gov/pubmed/1588280 | FC | NIH/3T3 Cells | MCP Transfected |
| Complement System | C6 | Depleted Sera | Cell Culture | A502 | C6 Depleted Sera | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/19484134 | WB | DU-145 Cells | |
| Complement System | C6 | Depleted Sera | Cell Culture | A502 | C6 Depleted Sera | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28632844 | WB | RPE Cells | |
| Complement System | C7 | Depleted Sera | Human | A503 | C7 Depleted Sera | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/19386604 | TER Measurements | ARPE-19 Cells | |
| Complement System | C7 | Depleted Sera | Cell Culture | A503 | C7 Depleted Sera | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22408008 | TER Measurements | RPE Cells | |
| Complement System | C7 | Depleted Sera | Cell Culture | A503 | C7 Depleted Sera | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/19484134 | WB | DU-145 Cells | |
| Complement System | C8 | Depleted Sera | Parasite | A504 | C8 Depleted Sea | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22451519 | FC | Entamoeba histolytica | |
| Complement System | C8 | Depleted Sera | Porcine | A504 | C8 Depleted Sera | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/26579969 | FC | Articular chondrocytes | |
| Complement System | C8 | Depleted Sera | Cell Culture | A504 | C8 Depleted Sera | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/19484134 | WB | DU-145 Cells | |
| Complement System | C9 | Depleted Sera | Cell Culture | A505 | C9 Depleted Sera | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/19484134 | WB | DU-145 Cells | |
| Complement System | Factor B | Depleted Sera | Cell Culture | A506 | Factor B Depleted Sera | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/26260209 | Complement Activation Assay | CHO Cells | |
| Complement System | Factor B | Depleted Sera | Human | A506 | Factor B Depleted Sera | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/19029031 | ELISA | Serum | |
| Complement System | Factor B | Depleted Sera | Human | A506 | Factor B Depleted Sera | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/25205869 | ELISA | Serum | |
| Complement System | Factor B | Depleted Sera | Human | A506 | Factor B Depleted Sera | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/29245944 | ELISA | HUVEC Cells | KSHV infection |
| Complement System | Factor B | Depleted Sera | Human | A506 | Factor B Depleted Sera | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23459111 | FC | Serum | Staphylococcus epidermidis incubated |
| Complement System | Factor B | Depleted Sera | Cell Culture | A506 | Factor B Depleted Sera | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/25254972 | IF | TIME-KSHV cells | |
| Complement System | Factor B | Depleted Sera | Cell Culture | A506 | Factor B Depleted Sera | 2020 | https://www.ncbi.nlm.nih.gov/pubmed/32054454 | IF | HNSCC Cells | |
| Complement System | Factor B | Depleted Sera | Human | A506 | Factor B Depleted Sera | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/24659767 | Serum Bactericidal Assay | Serum | Burkholderia cenocepacia incubated |
| Complement System | C3 | Depleted Sera | Cell Culture | A508 | C3 Depleted Sera | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/19019965 | Complement Activation Assay | Vero E6 cells | |
| Complement System | C3 | Depleted Sera | Human | A508 | C3 Depleted Sera | 2017 | https://pubmed.ncbi.nlm.nih.gov/27992410/ | Dot Blot | Serum | SPIO nanoworms |
| Complement System | C3 | Depleted Sera | Human | A508 | C3 Depleted Sera | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/29245944 | ELISA | HUVEC Cells | KSHV infection |
| Complement System | C3 | Depleted Sera | Cell Culture | A508 | C3 Depleted Sera | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/25254972 | IF | TIME-KSHV cells | |
| Complement System | C1q | Depleted Sera | Human | A509 | C1q Depleted Sera | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/26037225 | CDC Assay | Daudi Cells | |
| Complement System | C1q | Depleted Sera | Human | A509 | C1q Depleted Sera | 2021 | https://pubmed.ncbi.nlm.nih.gov/34796040/ | Complement Activation Assay | Serum | |
| Complement System | C1q | Depleted Sera | Cell Culture | A509 | C1q Depleted Sera | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/19019965 | Complement Activation Assay | Vero E6 cells | |
| Complement System | C1q | Depleted Sera | Human | A509 | C1q Depleted Sera | 2021 | https://pubmed.ncbi.nlm.nih.gov/34381048/ | ELISA | Plasma | |
| Complement System | C1q | Depleted Sera | N/A | A509 | C1q Depleted Sera | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/18962898 | ELISA | Purified protein | SLRP |
| Complement System | C1q | Depleted Sera | Human | A509 | C1q Depleted Sera | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/19029031 | ELISA | Serum | |
| Complement System | C1q | Depleted Sera | Human | A509 | C1q Depleted Sera | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23596522 | ELISA | Serum | C1q Depleted |
| Complement System | C1q | Depleted Sera | Human | A509 | C1q Depleted Sera | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/25205869 | ELISA | Serum | |
| Complement System | C1q | Depleted Sera | Human | A509 | C1q Depleted Sera | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27014840 | ELISA | Serum | Adenovirus incubated |
| Complement System | C1q | Depleted Sera | Human | A509 | C1q Depleted Sera | 2018 | https://www.ncbi.nlm.nih.gov/pubmed/29531170 | ELISA | Serum | Fc activation |
| Complement System | C1q | Depleted Sera | N/A | A509 | C1q Depleted Sera | 2018 | https://www.ncbi.nlm.nih.gov/pubmed/29868022 | ELISA | C1q Depleted Sera | |
| Complement System | C1q | Depleted Sera | Human | A509 | C1q Depleted Sera | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23459111 | FC | Serum | Staphylococcus epidermidis incubated |
| Complement System | C1q | Depleted Sera | Human | A509 | C1q Depleted Sera | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/26021447 | FC | Serum | Streptococcus pneumoniae |
| Complement System | C1q | Depleted Sera | Cell Culture | A509 | C1q Depleted Sera | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/25254972 | IF | TIME-KSHV cells | |
| Complement System | C1q | Depleted Sera | Cell Culture | A509 | C1q Depleted Sera | 2020 | https://www.ncbi.nlm.nih.gov/pubmed/32054454 | IF | HNSCC Cells | |
| Complement System | C1q | Depleted Sera | Human | A509 | C1q Depleted Sera | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/24659767 | Serum Bactericidal Assay | Serum | Burkholderia cenocepacia incubated |
| Complement System | C1q | Depleted Sera | Cell Culture | A509 | C1q Depleted Sera | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/19484134 | WB | DU-145 Cells | |
| Complement System | C1q | Depleted Sera | Cell Culture | A509 | C1q Depleted Sera | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28632844 | WB | RPE Cells | |
| Complement System | Factor P | Depleted Sera | Human | A512 | Factor P Depleted Sera | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21878570 | FC | Serum | |
| Complement System | Cobra Venom Factor | Reagent | Human | A600 | CVF, Cobra Venom Factor | 2020 | https://pubmed.ncbi.nlm.nih.gov/32209981/ | Complement Activation Assay | Plasma | |
| Complement System | Cobra Venom Factor | Reagent | Human | A600 | CVF, Cobra Venom Factor | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/19071065 | Complement Activation Assay | Plasma | Gold Nanoparticles incubated |
| Complement System | Cobra Venom Factor | Reagent | Human | A600 | CVF, Cobra Venom Factor | 2010 | https://www.ncbi.nlm.nih.gov/pubmed/20695636 | Complement Activation Assay | Plasma | |
| Complement System | Cobra Venom Factor | Reagent | Human | A600 | CVF, Cobra Venom Factor | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27647892 | Complement Activation Assay | Serum | |
| Complement System | Cobra Venom Factor | Reagent | Human | A600 | CVF, Cobra Venom Factor | 2022 | https://pubmed.ncbi.nlm.nih.gov/35947526/ | Complement Depletion Assay | Serum | |
| Complement System | Cobra Venom Factor | Reagent | Mouse | A600 | CVF, Cobra Venom Factor | 2005 | https://www.ncbi.nlm.nih.gov/pubmed/16201010 | Complement Depletion Assay | Protein Injection | |
| Complement System | Cobra Venom Factor | Reagent | Mouse | A600 | CVF, Cobra Venom Factor | 2008 | https://www.ncbi.nlm.nih.gov/pubmed/18495955 | Complement Depletion Assay | Protein Injection | |
| Complement System | Cobra Venom Factor | Reagent | Mouse | A600 | CVF, Cobra Venom Factor | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/19451240 | Complement Depletion Assay | Protein Injection | |
| Complement System | Cobra Venom Factor | Reagent | Mouse | A600 | CVF, Cobra Venom Factor | 2009 | https://www.ncbi.nlm.nih.gov/pubmed/19491392/ | Complement Depletion Assay | Protein Injection | |
| Complement System | Cobra Venom Factor | Reagent | Baboon | A600 | CVF, Cobra Venom Factor | 2012 | https://www.ncbi.nlm.nih.gov/pubmed/22909139 | Complement Depletion Assay | Protein Injection | |
| Complement System | Cobra Venom Factor | Reagent | Mouse | A600 | CVF, Cobra Venom Factor | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23238564 | Complement Depletion Assay | Protein Injection | |
| Complement System | Cobra Venom Factor | Reagent | Mouse | A600 | CVF, Cobra Venom Factor | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23817414 | Complement Depletion Assay | Protein Injection | |
| Complement System | Cobra Venom Factor | Reagent | Mouse | A600 | CVF, Cobra Venom Factor | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/24119087 | Complement Depletion Assay | Protein Injection | |
| Complement System | Cobra Venom Factor | Reagent | Mouse | A600 | CVF, Cobra Venom Factor | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/24279761 | Complement Depletion Assay | Protein Injection | |
| Complement System | Cobra Venom Factor | Reagent | Porcine | A600 | CVF, Cobra Venom Factor | 2014 | https://www.ncbi.nlm.nih.gov/pubmed/24999364 | Complement Depletion Assay | Protein Injection | |
| Complement System | Cobra Venom Factor | Reagent | Rat | A600 | CVF, Cobra Venom Factor | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25807289 | Complement Depletion Assay | Protein Injection | |
| Complement System | Cobra Venom Factor | Reagent | Mouse | A600 | CVF, Cobra Venom Factor | 2015 | https://www.ncbi.nlm.nih.gov/pubmed/25873375 | Complement Depletion Assay | Protein Injection | |
| Complement System | Cobra Venom Factor | Reagent | Human | A600 | CVF, Cobra Venom Factor | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/26564985 | Complement Depletion Assay | Serum | |
| Complement System | Cobra Venom Factor | Reagent | Baboon | A600 | CVF, Cobra Venom Factor | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27045379 | Complement Depletion Assay | Protein Injection | |
| Complement System | Cobra Venom Factor | Reagent | Rat | A600 | CVF, Cobra Venom Factor | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27765056 | Complement Depletion Assay | Protein Injection | |
| Complement System | Cobra Venom Factor | Reagent | Rat | A600 | CVF, Cobra Venom Factor | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27909702 | Complement Depletion Assay | Protein Injection | |
| Complement System | Cobra Venom Factor | Reagent | Mouse | A600 | CVF, Cobra Venom Factor | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28103139 | Complement Depletion Assay | Protein Injection | |
| Complement System | Cobra Venom Factor | Reagent | Human | A600 | CVF, Cobra Venom Factor | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28747785 | Complement Depletion Assay | Serum | |
| Complement System | Cobra Venom Factor | Reagent | Mouse | A600 | CVF, Cobra Venom Factor | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28966117 | Complement Depletion Assay | Serum | |
| Complement System | Cobra Venom Factor | Reagent | Mouse | A600 | CVF, Cobra Venom Factor | 2013 | https://www.ncbi.nlm.nih.gov/pubmed/23451163 | IF | Ear dermis Tissue | |
| Complement System | Cobra Venom Factor | Reagent | Human | A600 | CVF, Cobra Venom Factor | 2021 | https://pubmed.ncbi.nlm.nih.gov/34380648/ | WB | Purified protein | |
| Complement System | C1q | Antibody | Human | A700 | C1q Antibody (monoclonal) biotin | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/26047793 | Binding Assay | Serum | dnDSA |
| Complement System | C1q | Antibody | Mouse | A700 | C1q Antibody (monoclonal) biotin | 2010 | https://www.ncbi.nlm.nih.gov/pubmed/20004473 | ELISA | Intestinal Lysate | |
| Complement System | C1q | Antibody | Cell Culture | A700 | C1q Antibody (monoclonal) biotin | 2017 | https://pubmed.ncbi.nlm.nih.gov/28634480/ | FC | Raji cells | |
| Complement System | C3c | Antibody | Human | A701 | C3c Antibody (monoclonal) biotin | 2016 | https://pubmed.ncbi.nlm.nih.gov/27412887/ | FC | Serum | Platelet factor 4 (PF4)/heparin complexes |
| Complement System | C3d | Antibody | Human | A702 | C3d Antibody (monoclonal) biotin | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21860027 | FC | Red Blood Cells | |
| Complement System | C3d | Antibody | Human | A702 | C3d Antibody (monoclonal) biotin | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28251805 | FC | Endothelial Cells | |
| Complement System | C3d | Antibody | Human | A702 | C3d Antibody (monoclonal) biotin | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28678869 | FC | Plasma | HIV |
| Complement System | C3d | Antibody | Human | A702 | C3d Antibody (monoclonal) biotin | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28926521 | FC | Serum | HLA Positive |
| Complement System | C4d | Antibody | N/A | A704 | C4d Antibody (monoclonal) biotin | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28251805 | FC | Single Antigen Flow Bead (CVF Treated) | |
| Complement System | C5 | Antibody | Human | A705 | C5 Antibody (monoclonal) biotin | 2021 | https://pubmed.ncbi.nlm.nih.gov/34440207/ | ELISA | Plasma | |
| Complement System | C6 | Antibody | Human | A706 | C6 Antibody (monoclonal) biotin | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21839519 | ELISA | Plasma | |
| Complement System | C6 | Antibody | Human | A706 | C6 Antibody (monoclonal) biotin | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21964028 | ELISA | Serum | |
| Complement System | C6 | Antibody | Porcine | A706 | C6 Antibody (monoclonal) biotin | 2011 | https://www.ncbi.nlm.nih.gov/pubmed/21964028 | ELISA | Serum | |
| Complement System | C6 | Antibody | Human | A706 | C6 Antibody (monoclonal) biotin | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/26612199 | ELISA | Plasma | |
| Complement System | C6 | Antibody | Human | A706 | C6 Antibody (monoclonal) biotin | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/28002439 | ELISA | Serum | Myocardial necrosis, vascular damage and inflammation |
| Complement System | C6 | Antibody | Human | A706 | C6 Antibody (monoclonal) biotin | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28667310 | ELISA | Plasma | |
| Complement System | C6 | Antibody | Human | A706 | C6 Antibody (monoclonal) biotin | 2017 | https://www.ncbi.nlm.nih.gov/pubmed/28720697 | ELISA | Plasma | |
| Complement System | iC3b | Antibody | Human | A710 | iC3b Antibody (monoclonal) biotin | 2016 | https://www.ncbi.nlm.nih.gov/pubmed/27044740 | ELISA | Serum | |
| Complement System | Bb | Antibody | Mouse | A712 | Factor B (Bb) Antibody (monoclonal) biotin | 2010 | https://www.ncbi.nlm.nih.gov/pubmed/20004473 | ELISA | Intestinal Lysate | |
| Complement System | Multiplex | Multiplex | Human | A900 | Complement Multiplex - 8-plex | 2021 | https://pubmed.ncbi.nlm.nih.gov/33646629/ | ELISA | Plasma | Multiple Sclerosis |
| Complement System | Multiplex | Multiplex | Human | A900 | Complement Multiplex - 8-plex | 2021 | https://pubmed.ncbi.nlm.nih.gov/33995361/ | ELISA | Peripheral blood mononuclear cells | |
| Complement System | Multiplex | Multiplex | Human | A900 | Complement Multiplex - 8-plex | 2021 | https://pubmed.ncbi.nlm.nih.gov/34066885/ | ELISA | CSF | Primary CNS Vasculitis |
| Complement System | Multiplex | Multiplex | Human | A900 | Complement Multiplex - 8-plex | 2021 | https://pubmed.ncbi.nlm.nih.gov/34066885/ | ELISA | Serum | Primary CNS Vasculitis |
| Complement System | Multiplex | Multiplex | Human | A900 | Complement Multiplex - 8-plex | 2021 | https://pubmed.ncbi.nlm.nih.gov/34569094/ | ELISA | Serum | MOGAD |
| Complement System | Multiplex | Multiplex | Human | A900 | Complement Multiplex - 8-plex | 2023 | https://pubmed.ncbi.nlm.nih.gov/36752022/ | ELISA | Plasma | Myasthenia gravis |
| Complement System | Multiplex | Multiplex | Human | A901 | Complement Multiplex - 5-plex | 2021 | https://pubmed.ncbi.nlm.nih.gov/34914824/ | ELISA | Plasma | Multisystem inflammatory syndrome in children |